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Recent development of Systems Biology in this “omics” era reinforced the 
therapeutic strategy of considering human systems as a whole. This “holistic” 
approach had been long practiced in traditional medicines such as traditional Chinese 
medicine (TCM). Multi-herb prescriptions have been routinely used in TCM 
formulated by using TCM-defined herbal properties (TCM-HPs) where the scientific 
basis is unclear. These multi-herb prescriptions often include special herb-pairs 
responsible in mutual enhancement, assistance, and restraint. Machine learning 
methods (MLMs) such as support vector machine (SVM) are used to explore the 
scientific basis of TCM prescription formulation. The studies reveal that MLMs are 
capable of classifying TCM prescriptions and herb pairs from those of random herb 
combinations showing that there is hidden scientific rule in the formulation of TCM 
prescriptions for which the molecular mechanisms are still unknown. Besides, a 
structural approach using inverse docking method (INVDOCK) is used to identify 
putative metastatic-related targets of Rhubarb anthraquinones such as emodin, aloe-
emodin, and rhein from a protein structure database. Some targets identified by 
INVDOCK had been confirmed experimentally. The results implicate additive or 
synergistic effects of Rhubarb anthraquinones in anti-metastasis when used in 
combinations. In addition, current study of herbal synergism using literature-based 
approach reveals multiple mechanisms that involve either similar or distinct molecular 
targets as well as signaling pathways. In general, current in silico approaches used in 
this study covered both traditional and molecular aspects of TCM from top-down and 
bottom-up directions. More rigorous studies in the understanding of holistic 
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pharmacological mechanisms of TCM are needed and are believed to provide insight 
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Chapter 1 Introduction: Overview of Current Status in TCM 
Research and the Motivation in this Study  
 
 
 In the following subsections of this chapter the current status of drug discovery in 
this “omics” era and the rise of systems biology that reinforce “holistic” approach that 
subsequently lead us to face a paradigm shift in both philosphy and strategy in medicine 
are discribed. The reason why it is important to rethink our current approaches at this 
time in medicine and the necessity to revisit the study of traditional medicines such as 
traditional Chinese medicine (TCM) is explained. At the end of this chapter the 
motivation and approaches used in this study are presented. 
 
1.1 The Need of Revisiting the Research on TCM 
 
Plants have been used to treat diseases for more than a thousand of years. 
However, it was not until 1800s that pure compounds were isolated from plants, paving 
the way for modern pharmaceuticals. For instance, in 1805 morphine was isolated from 
the opium poppy (Papaver somniferum) by the German pharmacist Friedrich Serturner. 
Following the isolation of salicylic acid or aspirin from the bark of the willow tree (Salix 
alba), Felix Hoffmann synthesized aspirin in 1897. In the same year of first synthesis of 
aspirin, ephedrine was isolated from the Chinese herb Ephedra (Ma Huang) and became 
popular with American physicians in 1924 for its broncho-dilatating and decongestant 
properties [Fan et al. 2006]. In 1972 the antimalarial drug artemisinin was developed 
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from the Chinese herb Artemisia annua L (Qing Hao). All these examples illustrate the 
rich history of plant-based medicines. 
 
The proposal of the “Magic Bullet” theory by Paul Ehrlich in early 1900s [Winau 
et al. 2004] had directed pharmaceutical research towards target-directed drug discovery. 
Target-based screening was initially used to improve the drug-like properties of active 
compounds and their binding selectivity against pharmacological targets. This strategy 
was very successful when applied to well validated targets of known drugs. However, 
when the drug discovery process moved beyond these well validated targets it became 
apparent that the target-directed approach was flawed when testing on animal models and 
on human. This is due to the fact that most diseases such as diabetes, high blood pressure, 
high cholesterol levels and cancers are multi-factorial and that treating a single target 
provides only partial treatment. Although this awareness is not new it has been very 
difficult to find alternative routes due to the complexity of the living systems. 
 
However, the revolution in the past decade in the “omics” areas such as genomics, 
proteomics, and metabolomics in biology has provided considerable support for a more 
holistic view on diagnosis and treatment. Besides, the issue of personalized medicine is 
now receiving considerable attention due to the new insights in pharmacogenomics 
[Wang et al. 2005e]. Although there are around 30,000 genes in the human genome only 
600 to 1500 genes are estimated as potential drug targets [Hopkins et al. 2002]. Around 
6000 marketed drugs interact with less than 120 molecular targets. Of particular 
relevance is the fact that 61% of the 877 drugs introduced between 1981 and 2002 are 
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obtained from natural products or their synthetic derivatives [Newman et al. 2003; 
Newman et al. 2007]. TCM herbs are rich sources of active compounds. For instance, 
numerous bioactive compounds have been found in Chinese medicinal plants for diabetes. 
These compounds include polysaccharides, terpenoids, flavonoids, sterols and alkaloids, 
and some of them have been developed as new drugs and are used in clinical treatment of 
diabetes in China [Li et al. 2004]. 
 
Recently there is indication showing that expenses spent in drug development 
increased dramatically while limited drugs are approved as shown in Figure 1.1 [Service 
2004]. Hence, we are now experiencing a paradigm shift from growing evidences of the 
multifactorial nature of diseases. Various evidences had showed that the therapeutic 
effects of a combined-drug therapy or drug cocktail not only produce higher therapeutic 
efficacy but the side effects are not necessarily additives but even less than the sum of 
toxicity from single-drug therapy. Combinatorial drug therapies had been used in cancer 
chemotherapies, HIV infection, and hypertension. More detail of combinatorial drug 



















Figure 1.1 Costs spent and approved clinical drugs over years in the process of drug 












Similar to Western combinatorial drug therapy, TCM uses mixtures of plant 
extracts to maximize efficacy and minimize adverse effects or toxicity. In fact, 
multitarget therapy has long been exploited in TCM in the form of multi-herb 
prescriptions. By its very nature, a TCM prescriptions works by attacking as well as 
modulating several targets simultaneously. However, a multitude of challenges exist in 
plant-based medicine. First, there are many active compounds present in each herb and 
the synergistic and antagonistic interactions between active compounds from different 
herbs are largely unknown. Furthermore individual active compounds are usually less 
potent than the total herbal extract from which they are isolated. In fact some herbal 
compounds are prodrugs and are active only after absorption and metabolism.  
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In order to appreciate the holistic nature of TCM a brief description of theories 
used in TCM is presented. TCM has a long history dating back several thousands of years 
in China and is highly influenced by the development of Chinese culture. There are two 
main ideological ideas fundamental to TCM. The first is the homeostasis idea that 
focuses on the integrity of human body that emphasizes close relationship between 
human body and its social and natural environment (integrity between human and the 
cosmos). The second is the idea of dynamic balance that emphasizes the integrity of 
movement. Physiologically speaking TCM perceives human body in a cybernetic way. 
The important theories in TCM are the Yin-Yang theory, the Wu Xing (five elements) 
theory, as well as the Zhang Fu (meridians) theory that are used to explain the changes in 
the human body and to guide the diagnosis and treatment. 
 
1.2.1 The Yin-Yang Theory 
 
One of the most influential doctrines is the establishment of the Yin-Yang theory 
that had helped in the use of herbal materials for relieving illnesses. In Yin-Yang theory, 
the concept of Yin-Yang means “opposites” or “relatively speaking” such as hot vs cold, 
active vs inactive, healthy vs ill, etc [Zhang 2005a]. According to the Yin-Yang theory 
everything in the universe can be divided into Yin and Yang that are interchangeable as 
consistent with the modern scientific views of homeostasis where a biological system can 
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function to exert positive effect to one biological system but produce negative effect on 
another. In a more concise description, Yin and Yang are said to be complemented and 
rooted on each other [Zhang 2005a]. This produces mutual assistance, mutual 
conteraction, mutual suppression, and mutual antagonism of Yin-Yang actions. 
 
Physiologically, Yin controls the internal, lower and front portions of the body, 
while Yang dominates the external, upper and back parts of the body. In addition, Yin also 
represents passiveness, coolness, static, downward, descending, and hypofunctional, 
while Yang represents activeness, hotness, dynamic, upward, ascending, and 
hyperfunctional. When the homeostasis of the autonomic nervous system is compared to 
the Yin-Yang theory, Yang seems to resemble the functions of sympathetic nervous 
system that mediates hyperactivities in the body while Yin resembles the functions of 
parasympathetic nervous system that mediates hypoactivities in the body. The use of 
acupuncture, moxibustion and herbal medicines in TCM thus aim to rectify the imbalance 
of physiological Yin-Yang states. 
 
Recently, Ou et al defined the physical meaning of Yin-Yang in TCM by 
correlating it with biochemical processes. They proposed that Yin-Yang balance is 
correlated to antioxidation-oxidation balance with Yin representing antioxidation and 
Yang as oxidation. Their proposal is partially supported by the fact that the Yin-tonic 
traditional Chinese herbs on average have about six times more antioxidant activity and 
polyphenolic contents than the Yang-tonic herbs [Ou et al. 2003a]. More works to 
explore other biochemical espects of Yin-Yang are needed. 
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1.2.2 The Wu Xing theory (the theory of five elements) 
 
Another important doctrine in TCM is the Wu Xing Theory (the theory of five 
elements). According to Wu Xing theory every process in this world is cyclic and is 
maintained in a kinetic balance that can be relatively categorized into five different stages 
that correspond to activation (“wood” stage), ascending (“fire” stage), transition from 
active to inactive (“soil” stage), declining (“metal” stage), inactive or dormant (“water” 
stage) and the cycle repeats to active (“wood” stage) again. There are two opposite cycles 
in the Wu Xing theory. One is generative (positive influence) and the other suppressive 
(negative influence). In the generating cycle, wood generates fire, fire generates earth, 
earth generates metal, metal generates water and water generates wood. In the 
suppressive cycle, wood suppresses earth, earth suppresses function of water, water 
suppresses fire generation, fire suppresses the function of metal, and metal suppresses 
generation of wood. In TCM, the physiological and psychological functions of the body 
are symbolically represented by five elementary components according to the Wu Xing 
theory. 
 
1.2.3 The Zhang Fu theory (the theory of meridians) 
 
The Zhang Fu theory explains the integrity of whole body by a cybernetic way as 
well as the pathophysiological states and locations of diseases. The words “Zhang Fu” in 
Chinese mean organs. However, in TCM it is more on body systems that are connected 
by meridians or “Jing Luo” in Chinese. For instance, when a TCM practitioner mentions 
the term “kidney” he does not means the organ kidney as mentioned in Western medicine 
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from the anatomical point of view but rather the meridian of “kidney” that can be 
composed of excretory and reproductory systems as well as part of symphatetic and 
parasympathetic nervous systems. Hence, the concept of “Zhang Fu” or meridians in 
TCM is “systemic” rather than “organic”.  
 
1.2.4 Diagnosis and treatment in TCM 
 
In TCM the mind and the body are considered as one entity that involves signs 
and symptoms (or “Zheng” in Chinese) of illness rather than simply the cause of the 
disease. Practitioners of TCM diagnose the physiological Yin-Yang imbalance via 
“diagnosis of four” that comprises examining the patients by outlook, hearing the voice 
or breathing of patient, asking the illness states and the daily life style of patient, and 
examining the pulse. Each TCM herb has its own character and taste that corresponds to a 
particular Yin-Yang state. The TCM practitioner adjusts the imbalance of the Yin-Yang 
state in a patient by using multiple TCM herbs in a prescription or acupuncture as well as 
moxibustion.  
 
In general, the treatments of TCM are “phenome-based” that rely on the whole-
body response as revealed in signs and symptoms (“Zheng” in Chinese) display on 
patients irregardless of sources of infections. Each sign and symptom has the 
corresponding treatment which counterbalances the patient's disease states from normal 
health. Patients who show similar symptoms are relieved by the same treatment, even 
though the signs or symptoms may arise from different types of pathogens. Practitioners 
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of TCM select the appropriate treatment during the course of the disease as well as 
altering treatment to counterbalance the changes during disease development.  
 
1.2.5 Pharmacological classification of TCM herbs 
 
Each TCM herb possesses its own characters such as warm, hot, cool, or cold, 
tastes such as sweet, salty, pungent and the meridians such as heart or kidney where the 
herb exerts its therapeutic effect. The detailed descriptions of these properties of herb will 
be given in Chapter 2 and 3. In clinical application, TCM herbs are classified into 18 
groups [Cheng 2000]. Some of these classes are similar to the therapeutic groups used in 
Western medicine. These classes are digestives, anthelmintics, purgatives (cathartics), 
diuretics, expectorants, and antitussives. However, some groups have no equivalent in 
Western medicine, such as herbs for relieving exterior syndrome, herbs for eliminating 
heat, herbs for eliminating wind dampness, herbs for dispelling dampness, herbs for 
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TCM Pharmacological Class 
1 Herbs for relieving exterior syndromes 
2 Herbs for eliminating heat 
3 Herbs for purgation  
4 Herbs for eliminating wind dampness 
5 Herbs for dispelling dampness 
6 Diuretics 
7 Herbs for warming the interior 




12 Herbs for activating blood circulation and removing blood stasis 
13 Dyspnea relieving herbs 
14 Sedatives 
15 Herbs for calming the liver and suppressing wind 





1.3 TCM Research in the “Omics” Era 
 
 
Recent developments in genomics, proteomics and metabolomics have advanced 
researches in life sciences including herbal medicines. In this “omics” era an 
unprecedented array of analytical tools has made a great forward leap in the 
understanding of the philosophy as well as scientific foundation of TCM prescriptions. 
Hence, reseaches on TCM in these days are not merely limited to animal testing from 
isolated active compounds, herbal extracts or multi-herb decoctions but to analyze 
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profiles as a whole in the disipline of systems biology in term of gene expression as well 
as proteome after taking these ingredients.   
 
Microarray analysis has been applied to analyze gene expression on herbal recipes 
to study various diseases using animal models such as ischemic mice [Wang et al. 2004]. 
Besides, metabolome analysis that comprises of metabolite profiling is of growing 
importance in herbal medicine such as breeding, formulation, quality control and clinical 
trials [Kell 2004; Chan et al. 2007]. Methods that are currently being used in 
metabolomics are chromatography-based methods such as gas chromatography (GC), 
high performance liquid chromatography (HPLC); molecular weight-based methods such 
as mass spectrometry (MS); and physical characteristics-based methods such as NMR 
spectrometry.  
 
1.4 In Silico Approaches in TCM Research 
 
The development of “omics” research is not possible without the advancement of 
various in silico approaches used in genomics and bioinformatics. These in silico 
approaches include molecular docking, molecular dynamics simulation, machine learning 
methods, quantitative structure-activity relationship analysis (QSAR), local and global 
sequence alignment and comparison algorithms, data mining and pattern recognitions.  
 
Recently some of these in silico methods have been used in TCM research. For 
instance, the Bayesian network has been used to deal with the information of symptoms 
and signs for syndrome differentiation [Zhu et al. 2006]. In addition, Bayesian network 
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was also used to model the relationship between quantitative features and diseases as 
extracted from tongue images [Pang et al. 2004]. Besides symptom recognition, 
computerized binary coding was used to decompose and reconstruct the Yin-Yang theory 
and was proven to be a successful simulation of the major ingredients of the theory 
further suggested the possibility of digitalization of the fundamental theories in TCM 
[Qin et al. 2004]. Recent work by Wang et al used machine learning approach to validate 
TCM herbal prescriptions [Wang et al. 2005b]. In addtion, the fingerprint analysis 
techniques used in the quality control of TCM via identifying characteristics and 
evaluating stability is set up with rapid development of instrumental analyses and 
computer pattern interpretation. Methods of computer pattern recognition in TCM 
figerprint include fuzzy information analysis, artificial neural networks and gray 
relational grade cluster [Su et al. 2001].  
 
1.5 Motivation and In Silico Approaches Used in this Study 
 
 
As discussed from previous subsections in this chapter, it is necessary to revisit 
the research on TCM and to rethink on current philosophy and strategy in medicine and 
drug development. The principal objective of the study of Chinese herbal formulations is 
to determine whether they may represent a platform for the development of novel 
therapeutics from the holistic point of views as currently reinforced in systems biology. 
Of course this is not a simple exercise of applying modern technologies and clinical 
designs to products that had been constantly used for some time. There are totally 
different philosophies of Western and Chinese medical practices towards human health. 
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Western medicine looks at the relationship between structure and function and target-
driven drug design against pathogens and diseases. Chinese medicine, on the other hand, 
defines health in terms of balance and its medications are designed such that to restore 
health balance by interacting with a variety of targets where the mechanisms are largely 
unknown. However, there are arguments saying that the resulting medication effects of 
herbal prescriptions are due to placebo factors. 
 
Although there are attempts of using in silico approaches to study TCM as 
described in section 1.4, the question of whether there is scientific basis of TCM practice 
is still not answered. Hence, the main motivation in this study is to explore the scientific 
basis of TCM. Two aspects of TCM are explored: from the traditional point of views 
described in TCM and from the level of molecular interactions. In silico approaches are 
used to study TCM in both traditional and molecular levels. In silico methods used in this 
study are supervised machine learning methods that include support vector machine 
(SVM), k-nearest neighbors (kNN) and probabilistic neural network (PNN), structural 
approach using inverse docking strategy (INVDOCK), and literature-based approach. 
The detail of these methods will be given in their respective chapters. 
 
Chapter 2 and 3 discuss the work of using machine learning methods such as 
support vector machine (SVM) to study the pattern recognition in TCM prescriptions and 
herb pairs from traditional point of views, respectively. Chapter 4 and 5 present the 
study of TCM at the molecular levels. In Chapter 4, structural approach using an inverse 
docking strategy was used to explore the metastasis-related targets of Rhubarb 
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anthraquinones such as emodin and aloe-emodin. In Chapter 5, a literature-based 
approach is conducted to search for the molecular mechanisms of herbal synergism. 
Finally, in the last chapter (Chapter 6) describes major findings and contributions of 
current work to the progress of using in slico approaches for studying TCM herbal 
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Chapter 2 Use of Machine Learning Methods (MLMs) in the 
Study of TCM from the Traditional Point of Views  
 
 
Traditional Chinese medicine (TCM) has been widely practiced and is considered as an 
attractive alternative to conventional medicine. The holistic approach of TCM is realized 
by multi-herbal prescriptions using TCM-defined herbal properties (TCM-HPs). 
However, the scientific basis of TCM-HPs is unclear. In this chapter, machine learning 
methods (MLMs) are used to “dig out” the hidden scientific rules within TCM-HPs used 




          Traditional medicines such as Traditional Chinese medicine (TCM) have been 
widely used for disease treatment and have been recognized as interesting alternatives to 
complement conventional medicine [Tang et al. 1992; Chan 1995b; Chen 1998; Yuan et 
al. 2000b; Ang-Lee et al. 2001a; Bhuiyan et al. 2003; Wang et al. 2003; Lazar 2004a]. 
These multi-herb recipes collectively exert therapeutic actions and modulating the 
pharmacological and toxicological effects of the chemical ingredients of the constituent 
herbs. The principle ingredients are believed to provide main therapeutic actions, 
secondary principle ingredients enhance or assist the effects of the principle ones, and the 
rest serve modulating roles such as treatment of accompanying symptoms, moderation of 
harshness and toxicity, enhancement of pharmacokinetic properties, and harmonization 
etc [Yuan et al. 2000b].   
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Multi-herb TCM prescriptions have been formulated by using traditional prescribing 
principles based on traditionally defined TCM herbal properties (TCM-HPs)[Li 2005], 
and by taking into such considerations as the disease stage and the conditions of an 
individual patient [Chan 1995b]. Table 2.1 gives a complete list of TCM-HPs which 
include four fundamental characters (cold, cool, warm and hot), five fundamental tastes 
(salty, sour, bitter, sweet and pungent), four toxic states (toxic, non-toxic, very toxic, and 
slightly toxic), and 12 meridians (bladder, spleen, large intestine, stomach, small intestine, 
liver, cardiovascular, heart, kidney, gallbladder, xin bao or pericardium and san jiao). By 
using these TCM-HPs, herbs are combined for achieving mutual enhancement, mutual 
assistance, mutual restraint, mutual suppression, or mutual antagonism [Chan 1995b]. 
TCM prescription is a combination of “Master” (for principal diseases or symptoms), 
“Adviser” (for helping the “Master” and treating accompanying symptoms), “Soldier” 
(for modulating the effects of the “Master” and “Adviser” and restoring the body to pre-
illness equilibrium) and “Guide” (for guiding active ingredients and harmonizing the 
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Table 2.1 List of Traditional Chinese Medicine herbal properties (TCM-HPs). These properties are classified into four classes, 
characters (Class C), tastes (Class T), meridians (Class M), and toxicity states (Class Tox). These are further divided into 5, 5, 
2, and 2 sub-classes for C, T, M and Tox respectively, each of which include 11, 12, 12, and 4 TCM-HPs. The total number of 
unique TCM-HP vector for all TCM herbs is 11+12+12+4 = 39.  
List of TCM herbal properties (TCM-HPs) 
Character Class (C) Taste Class (T) Meridian Class (M) Toxicity State Class (Tox) 
Subclass  
(5 in total) 
TCM-HP (11 in 
total) 
Subclass  
(5 in total) 
TCM-HP  
(12 in total) 
Subclass  
(2 in total) 
TCM-HP  
(12 in total) 
Subclass  
(2 in total) 
TCM-HP  
(4 in total) 
C1: Slightly cold T1:  Slightly salty M1: Liver  Tox1: Severely 
toxic 
M2: Heart  C2: Cold 
M3: Xin Bao 
Tox2: Toxic 
CI: Cold 
C3: Severely cold 
TI: Salty 
T2:  Salty 
M4: Spleen  

















T6: Slightly bitter 
 
M7: Bladder 







 M9: San Jiao 
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                The assumed usefulness of TCM-HPs for formulating TCM prescriptions is 
likely arising from the expected correlation between TCM-HPs and the physicochemical 
properties of the ingredients of the constituent herbs responsible for collectively 
producing the specific pharmacodynamic, pharmacokinetic, and toxicity-modulating 
effects. While details of this correlation remain to be determined, the usefulness of TCM-
HPs can be studied by analyzing the statistical pattern of the collective TCM-HPs of the 
well established TCM prescriptions to find out whether the distribution show signs of 
synergy among the constituent herbs in each prescription. Moreover, previous work had 
showed that machine learning methods (MLMs) such as support vector machine (SVM) 
can be used to evaluate whether TCM-HPs are capable of distinguishing TCM 
prescriptions from non-TCM recipes [Wang et al. 2005a]. 
 
               A TCM-HP digitization algorithm has been developed and used for computing 
digital TCM-HPs, which have been applied for clustering and classifying TCM 
prescriptions[Su 1997; Wang et al. 2005a]. However, by using this algorithm, the number 
of digital TCM-HPs for each recipe is dependent on the number of its constituent herbs, 
which gives feature vectors of un-equal components thereby introducing statistical noise 
to many MLM systems. Therefore, in this study, a new algorithm was introduced to 
derive digital TCM-HPs of fixed length independent of the number of constituent herbs 
in a recipe. Besides, a significantly higher number of TCM prescriptions and non-TCM 
recipes than those in other studies [Wang et al. 2005a] were used for training and testing 
the MLM systems. Moreover, two different MLMs were used, which were evaluated by 
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two separate testing methods, to adequately examine the usefulness of TCM-HPs in 
distinguishing between TCM prescriptions and non-recipes.  
 
                In addition to the assessment of the usefulness of TCM-HPs, the developed 
MLM classification systems may be potentially used for facilitating the validation of 
TCM prescriptions[Wang et al. 2005a]. This capability was tested by using a group of 48 
recently published TCM prescriptions with both experimental and clinical data that are 
not used in developing the MLM classification systems. Formulation of TCM 
prescriptions often relies on practitioner’s experience and intuition as well as one’s 
knowledge of TCM herbal properties and the formulation principles. This task is further 
complicated by the personalized nature of TCM prescriptions. A particular difficulty is 
the validation of a newly constructed TCM prescription to answer questions such as 
whether it strictly conforms to the TCM formulating principles. Such a task may be 




2.2.1 Selection of TCM prescriptions and non-TCM recipes 
 
 
              TCM prescriptions were selected from authoritative TCM prescription books 
and TCM commercial product handbooks[Yang 2001; Zhang 2005b; Sun 2006; Chen 
1998; Zhang 1998a; Zhang 1998b]. The quality of the selected TCM prescriptions is 
maintained by the requirement that they satisfy at least one of the following three 
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conditions: (1) well known for many years of clinical application, (2) a commercial 
product, (3) published in an established TCM journal. These TCM prescriptions were 
subsequently screened to remove those with incomplete knowledge about the TCM-HPs 
of constituent herbs to ensure that the selected prescriptions can be studied in this work. 
A total of 1,161 established TCM prescriptions (which satisfy the first condition), 183 
additional TCM prescriptions from a TCM book[Chen et al. 2002a], and 48 new TCM 
prescriptions from recently published journals were selected from this procedure. Figure 
2.1 shows the distribution of the 1,161 established TCM prescriptions with respect to the 
number of constituent herbs. It is found that most of the prescriptions (82.9%) are 
composed of 2~12 herbs, with 6-, 7-, 8-, 9- and 10-herb prescription groups (8.7%, 8.8%, 
10.2%, 9.2%, and 10.0%) constituting the groups with the largest number of prescriptions.  
Figure 2.1 Distribution of Traditional Chinese Medicine (TCM) prescriptions with 
respect to the number of constituent herbs. The distribution (in percentage) of 1161 TCM 
prescriptions in relation to the number of constituent herbs used in training set in this 
study is shown. Most of these TCM prescriptions contain 2 to 12 constituent herbs with 
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               Non-TCM recipes were generated by random combination of multiple herbs and 
by modification of existing TCM prescriptions. In the first approach, a total of 635 
commonly-used TCM herbs were divided into 13 traditionally-defined therapeutic classes 
described in the TCM literature[Hou 2001]. For each class, two herbs with TCM-HPs 
closest to the average values of the other herbs were selected as the representative for that 
class. These representative herbs were then randomly combined and subsequently 
checked to remove hits of known TCM prescriptions to ensure that the generated non-
TCM recipes are most likely to be true non-TCM recipes. This process gives rise to 
10,936 non-TCM recipes each of which contains 2 to up to 13 herbs. In the second 
approach, existing TCM prescriptions with knowledge of their “Master” herbs were 
modified by one of the following three methods to generate 266 non-TCM recipes. The 
first is the removal of the “Master” and in some cases the “Adviser” as well. The second 
is to replace the “Master” with those possessing the opposite TCM-HPs to completely 
disrupt the expected synergy between the original “Master” and the other herbs in the 
prescription. The third is to add a specific herb to form a disallowed or un-favored herb-
pair to convert the prescription into an invalid one. These “modified” recipes were 
subsequently checked to remove hits of known TCM prescriptions to ensure that the 
generated non-TCM recipes are most likely true non-TCM recipes. Overall, a total of 
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2.2.2 Digital representation of herbs and multi-herb recipes 
 
               As shown in Table 2.1, TCM-HPs are divided into 4 classes: character (C), 
taste (T), meridian (M), and toxicity level (Tox), which further divided into 5, 5, 12, and 
2 subclasses, and 11, 12, 12 and 4 TCM-HPs respectively. The total number possible of 
TCM-HP combinations is C×T×M×Tox = 11×12×12×4 = 6,336. The value of a TCM-HP 
is 1 or 0 if the herb possesses or does not possess the corresponding property. For 
instance, the herb Herba Ephedrae (Ma Huang) has warm character, pungent taste, 
meridians for lung and bladder, and is non-toxic. The TCM-HPs for Herba Ephedrae 
(Ma Huang) are C = (C1, C2, C3, C4, C5, C6, C7, C8, C9, C10, C11) = (0, 1, 0, 0, 0, 0, 0, 
0, 0, 0, 0), T = (T1, T2, T3, T4, T5, T6, T7, T8, T9, T10, T11, T12) = (0, 0, 0, 0, 0, 0, 0, 0, 
0, 1, 0, 0), M = (M1, M2, M3, M4, M5, M6, M7, M8, M9,  M10, M11, M12) = (0, 0, 0, 0, 
1, 0, 1, 0, 0, 0, 0, 0), Tox = (T1, T2, T3, T4)=(0, 0, 0, 1). This herb can then be digitally 
represented by using a feature vector x = C×T×M×Tox. Likewise, a multi-herb recipe can 
be digitally represented by a feature vector which is the sum of the feature vectors of the 
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2.2.3 Machine Learning Methods (MLMs) 
 
2.2.3.1  k-Nearest Neighbor (kNN) 
               
Figure 2.2 illustrates the computational process of kNN for determining whether 
a multi-herb recipe is a TCM prescription from the TCM-HPs of constituent herbs of 
multi-herb recipes. The Euclidean distance between an unclassified vector x (feature 
vector of a new multi-herb recipe) and each individual vector xi in the training set 
(feature vector of each known TCM prescription or non-TCM recipe) is 
measured[Johnson et al. 1982] by using the following formula: 2iD = −x x . A total of 
k number of vectors or k known TCM prescriptions and non-TCM recipes nearest to the 
unclassified vector x are used to determine the class (TCM prescription class or non-
TCM recipe class) of that unclassified vector (new recipe). The class of the majority of 
the k nearest neighbors is chosen as the predicted class of the unclassified vector x.  
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Figure 2.2 Schematic diagram illustrating the process of the prediction of Traditional 
Chinese Medicine (TCM) prescription from the traditionally described herbal properties 
of constituent herbs of a multi-herb recipe by using a machine learning method – k-
nearest neighbors. 
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2.2.3.2  Support Vector Machine (SVM) 
               Figure 2.3 illustrates the process of the prediction of TCM prescription by using 
SVM from the TCM-HPs of constituent herbs of multi-herb recipes. Known TCM 
prescriptions and non-TCM recipes in a training set, represented by their TCM-HPs, are 
projected onto a hyperspace where they are separated by a hyperplane whose parameters 
are adjusted by using a separate testing set of TCM prescriptions and non-TCM recipes. 
By projecting the feature vector of a new multi-herb recipe onto this same hyperspace, 
this SVM system can be used to determine whether it is a TCM prescription based on its 
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Figure 2.3 Schematic diagram illustrating the process of the prediction of Traditional 
Chinese Medicine (TCM) prescription from the traditionally described herbal properties 
of constituent herbs of a multi-herb recipe by using a machine learning method - support 
vector machines. A, B: feature vectors of TCM prescriptions; E, F: feature vectors of 
non-TCM recipes; filled circles, TCM prescriptions; filled squares, non-TCM recipes. 
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2.2.4 Determination of generalization ability of MLM classification systems 
 
             To adequately assess the classification ability of the SVM and kNN classification 
systems developed in this work, two different evaluation methods are used. One is the 3-
fold cross validation method, which as a special case of the N-fold cross validation 
method is one of the widely used methods for measuring the accuracies of MLM 
classification systems[Li et al. 2005a]. The other one is the use of external independent 
validation sets, which has been shown to be equally useful for evaluating the 
classification ability of MLM classification systems [Li et al. 2005a; Wang et al. 2005c]. 
 
               In using the 3-fold cross validation method, 1161 TCM prescriptions and 11,202 
non-TCM recipes were randomly divided into three subsets, with 389 TCM prescriptions 
and 3719 non-TCM recipes in subset 1, 384 and 3734 in subset 2, and 388 and 3749 in 
subset 3 respectively. Validation study can be conducted by using two subsets as the 
training set and the other as the testing set. Three distinct combinations of training-testing 
sets can be generated from these three subsets, which were used to conduct three 
iterations of validation studies. For the independent validation method, all the 1161 TCM 
prescriptions and 11,202 non-TCM recipes were used as the training set, and 183 TCM 
prescriptions from a TCM book[Chen et al. 2002a]  were used as an independent 
validation set. An additional independent validation set that consists of 48 TCM 
prescriptions from recently published literature was used to further test the outperformed 
MLM classification system.  
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             The performance of the kNN and SVM classification systems can be measured 
by the positive, negative and overall classification accuracies P+= TP/(TP+FN), P- = 
TN/(TN+FP) and P=(TP+TN)/N, which correspond to the accuracies for TCM 
prescriptions, non-TCM recipes, and all recipes respectively. Here TP, TN, FP, and FN 
are the number of true positive (correctly classified TCM prescription), true negative 
(correctly classified non-TCM recipe), false positive (TCM prescription falsely classified 
as non-TCM recipe), and false negative (non-TCM recipe falsely classified as TCM 




2.3.1 Distribution pattern of TCM-HPs and characteristics of TCM prescriptions 
 
               Figure 2.4 shows the distribution pattern of the TCM-HPs of the 1161 
established TCM prescriptions. These prescriptions are aligned along the x-axis from left 
to right in the order of the number of constituent herbs from 1-herb to up to 23-herb 
prescriptions. Each individual dot represents the TCM-HP of an individual herb in a 
TCM prescription. The TCM-HPs of all of the herbs in a TCM prescription are grouped 
into taste-character subclasses and they are aligned along the y-axis from bottom to top in 
the order of Salty-Cold, Salty-Cool, Salty-Neutral, Salty-Warm, Salty-Hot, Sour-Cold, 
Sour-Cool, Sour-Neutral, Sour-Warm, Sour-Hot, Bitter-Cold, Bitter-Cool, Bitter-Neutral, 
Bitter-Warm, Bitter-Hot, Sweet-Cold, Sweet-Cool, Sweet-Neutral, Sweet-Warm, Sweet-
Hot, Pungent-Cold, Pungent-Cool, Pungent-Neutral, Pungent-Warm, and Pungent-Hot. 
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Figure 2.4 Distribution pattern of the Traditional Chinese Medicine herbal properties 
(TCM-HPs) of 1161 TCM prescriptions. TCM prescriptions are aligned along the x-axis 
from left to right in the order of the number of constituent herbs from 1-herb to up to 23-
23-herb prescriptions. Each individual dot represents the TCM-HP of an individual herb 
in a TCM prescription. The TCM-HPs of all of the herbs in a TCM prescription are 
grouped into taste-character subclasses and they are aligned along the y-axis from bottom 
to top in the order of TI-CI, TI-CII, TI-CIII, TI-CIV, TI-CV, TII-CI, TII-CII, TII-CIII, 
TII-CIV, TII-CV, TIII-CI, TIII-CII, TIII-CIII, TIII-CIV, TIII-CV, TIV-CI, TIV-CII, TIV-
CIII, TIV-CIV, TIV-CV, TV-CI, TV-CII, TV-CIII, TV-CIV, TV-CV. The definition of 
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2.3.2 Usefulness of TCM-HPs for distinguishing TCM prescriptions from non-
prescription recipes 
 
               The usefulness of TCM-HPs for distinguishing TCM prescriptions from non-
TCM recipes can be assessed by examining whether MLM methods can use TCM-HPs to 
separate them Two MLM methods, kNN and SVM, were used for conducting this test. 
Table 2.2 gives the computed accuracies of these two methods by using 3-fold cross 
validation where 84.4% and 91.3% of the TCM prescriptions and 98.9% and 98.6% of 
the non-TCM recipes are correctly classified by kNN and SVM respectively. Testing 
results using the independent evaluation set shows that 83.1% and 97.3% of the TCM 
prescriptions are correctly classified by kNN and SVM respectively. Both validation 
methods consistently show that these two MLM methods are capable of using TCM-HPs 
to correctly separate TCM prescriptions from non-TCM recipes. It is possible that the 
distinguished characteristics of TCM-HPs of TCM prescriptions are exploited by the 
MLM methods for separating them from non-TCM recipes. As both validation methods 
show that SVM outperforms kNN, SVM is further tested by using the independent set of 
48 newly published TCM prescriptions with proven therapeutic effects in both 
experimental and clinical data. All of these 48 TCM prescriptions are correctly classified 
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Table 2.2  Traditional Chinese Medicine (TCM) prescription and non-TCM recipe 
classification accuracies of the machine learning classification systems, k Nearest 
Neighbor (kNN) and Support Vector Machine (SVM), evaluated by 3-fold cross 
validation study.  
 
Classification system: kNN 







TP FN P+ % TN FP P- % P % 
1 773 7453 341 47 87.9 3706 43 98.8 97.8 
2 777 7468 314 70 81.8 3699 35 99.1 97.4 
3 772 7483 325 64 83.6 3670 49 98.7 97.3 
Average 
Accuracy 
     
84.4 




SD     3.13   0.21 0.26 
Classification system: SVM 







TP FN P+ 
% 
TN FP P- % P % 
1 773 7453 360 28 92.8 3692 57 98.4 97.9 
2 777 7468 342 42 89.1 3684 50 98.6 97.7 
3 772 7483 358 31 92.0 3670 49 98.7 98.1 
Average 
Accuracy 
     
91.3 




SD     1.95   0.15 0.2 
 
P+, P- and P represent the classification accuracy for TCM prescriptions, non-TCM recipes and 
all recipes. TP, TN, FP, and FN are the number of true positive (correctly classified TCM 
prescriptions), true negative (correctly classified non-TCM recipes), false positive (TCM 
prescriptions falsely classified as non-TCM recipes), and false negative (non-TCM recipes falsely 
classified as TCM prescriptions) respectively, and N is the total number of recipes. Statistical 








CHAPTER 2 MLMs ON TCM                                                                                      32                                                   
 
2.3.3 Misclassified TCM prescriptions  
 
             There are 5 TCM prescriptions in the first independent set from Chen and Li 
[Chen et al. 2002a] incorrectly predicted by SVM method. The 5 misclassified TCM 
prescriptions are 11f13 (Natrii sulfas or Mang Xiao, Indigo Naturalis or Qing Dai, 
vinegar or Cu), 12f1 (Radix Glycyrrhizae or Gan Cao, Radix Kansui or Gan Sui), 12f12 
(Semen Arecae or Bing Lang, Fructus Evodiae or Wu Zhu Yu), 15f7 (Rhizoma Smilacis 
Glabrae or Tu Fu Ling, Radix Glycyrrhizae or Gan Cao), and 18f64 (Cordyceps sinensis 
or Dong Chong Xia Cao, Radix Adenophorae or Nan Sha Shen, Fructus Schisandrae or 
Wu Wei Zi, Radix Ophiopogonis or Mai Dong). Prescription 12f1 was incorrectly 
predicted as a non-TCM recipe possibly because it contains an unfavorable herb pair of 
Radix Glycyrrhizae (Gan Cao) and Radix Kansui (Gan Sui). One possible reason for the 
misclassification of prescription 11f13 as a non-TCM recipe is that vinegar (Cu) counters 
the effect of Natrii sulfas (Mang Xiao) and Indigo Naturalis (Qing Dai). The reason for 
the misclassification of the other 3 TCM prescriptions (12f12, 15f7, 18f64) remained to 
be elucidated.  
 
2.4 Discussion and Conclusion 
 
 
              The TCM-HP distribution pattern shows apparent internal correlation among the 
constituent herbs in a prescription particularly for those containing more than 6 herbs. For 
instance, herbs in the class of sweet-neutral, pungent-warm, sweet-warm, bitter-warm, 
and bitter-cold simultaneously appear in most of the prescriptions. At a slightly less level, 
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herbs in the class of sweet-cold and pungent-cold are also simultaneously present in these 
prescriptions. In these prescriptions, a general theme of herbal synergy seems to be 
exhibited by the TCM-HPs of their constituent herbs, and this theme is consistent with 
the TCM prescribing theory [Li 2005]. For instance, herbs in the class of bitter-cold have 
frequently been used for treating “hot” symptoms such as fever and inflammation. Herbs 
in the class of pungent-warm or bitter-warm have frequently been used for treating cold 
symptoms such as weak pulse, tiredness, favor of hot drink, whitish tongue, etc. Herbs in 
the class of sweet-warm and sweet-neutral have frequently been used for modulating the 
therapeutic and tonic activity as well as reducing the toxic effect of other constituent 
herbs. Overall, it appears that these prescriptions have been constructed on the basis of a 
delicate balance between herbs of warm characters and those of cold characters, with the 
warm effects of the warm herbs to various degrees counter-balanced by the cold effects 
of the cold herbs, and vice versa. This ensures the collective character of a prescription is 
not too biased towards the warm or cold side to overly correct the Ying-Yang state of a 
patient. Understanding the molecular mechanism of these collective actions enables 
advancement of systems biology and facilitates the design “soft drug cocktail” that 
targets and simultaneously modulates multiple systems in human. 
 
               Our study suggests that TCM-HPs are useful for distinguishing TCM 
prescriptions from non-TCM recipes. This supports the long held view in TCM theory 
that TCM-HPs can fully characterize TCM herbs and they can be used to formulate TCM 
prescriptions [Li 2005]. Moreover, these TCM-HPs are expected to be associated with the 
physicochemical properties of herbal ingredients responsible for producing the effects of 
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specific herb and the collective effects of specific TCM prescription. For instance, 
fluorometric analysis has shown that herbs with cold characters produce large amounts of 
superoxide, and herbs with hot characters have scavenging activities[Lin et al. 1995]. 
Specific group of “Yang-invigorating” herbs, which tend to have warm or hot characters, 
have been found to enhance mitochondrial ATP generation in addition to 
immunomodulatory activities[Yim et al. 2002; Ko et al. 2004; Siu et al. 2004]. Heat 
clearing herbs, which tend to have cold characters, have been found to produce some 
combination of anti-microbial, anti-toxic, anti-inflammatory, antipyretic, platelet 
aggregation inhibition, sedative, immunomodulatory, and hepatoprotective 
activities[Jiang 2005]. These studies suggest the merit for further studying the scientific 
basis of and for exploring TCM-HPs in developing multi-herb based therapeutics. 
 
               Several other factors might contribute to the misclassification of TCM 
prescriptions by MLMs. One is the possible inadequate representation of some of the 
TCM prescriptions in the training set. Some prescriptions have unique features not found 
in other prescriptions. Examples of such prescriptions are Liu Shen Wan, Tong Guan San, 
and Yun Nan Bai Yao. Their exclusion in the training set tends to make it difficult for an 
AI method to classify them into the correct class. The lack of information about the 
TCM-HPs for some herbs makes it impossible for classifying a substantial number of 
TCM prescriptions. So far, we were able to digitize only 1,161 of the 1,588 TCM 
prescriptions we have collected. These problems can be alleviated along with the 
availability of more TCM-HP data and TCM prescriptions. 
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                Our study also raises an interesting possibility of using MLM methods to 
validate TCM prescriptions by determining whether a multi-herb recipe is a valid TCM 
prescription from the TCM-defined herbal property. To further assess this potential, the 
performance of one of the MLM methods, SVM, for classifying TCM prescriptions was 
evaluated by using the additional independent evaluation set of 48 TCM prescriptions 
published in recent years. All of them were correctly classified as TCM prescriptions. 
Further improvement in the coverage of herbs and prescriptions, refinement of digital 
representation of recipes, and improvement of MLM algorithms may enable the 
development of MLMs into a useful tool for facilitating the evaluation of TCM 
prescriptions.  
 
CHAPTER 3 MLMs ON TCM HERB PAIRS 36 
 
Chapter 3 Pattern Analysis of TCM Herb Pairs Using Machine 
Learning Methods from the Traditional Point of Views 
 
Multi-herbal prescriptions of traditional Chinese medicine (TCM) often include special 
herb-pairs for mutual enhancement, assistance, and restraint. These TCM herb-pairs 
have been assembled and interpreted based on traditionally-defined herbal properties 
(TCM-HPs) without knowledge of mechanism of their assumed synergy. While these 
mechanisms are yet to be determined, properties of TCM herb-pairs can be investigated 
to determine if they exhibit features consistent with their claimed unique synergistic 
combinations. In this chapter we analyzed distribution patterns of TCM-HPs of TCM 
herb-pairs to detect signs indicative of possible synergy and used machine learning 
methods (MLMs) to examine whether combination of their TCM-HPs are distinguishable 
from those of non-TCM herb-pairs assembled by random combinations and by 




 Multi-herb recipes have frequently been used in TCM aimed at collectively 
exerting therapeutic actions and modulating the pharmacological and toxicological 
effects of the chemical ingredients of the constituent herbs. In formulating these TCM 
recipes, special herb pairs that are claimed to be unique combinations of the traditionally 
defined TCM herbal properties (TCM-HPs) [Li 2005] have been frequently used for 
achieving mutual enhancement, mutual assistance, mutual restraint, mutual suppression, 
or mutual antagonism [Chan 1995b].  
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 The exact molecular mechanisms of these TCM herb-pairs are unclear. None-the-
less, some possible modes of actions have been hypothesized [Yuan et al. 2000b]. Mutual 
enhancement can be achieved by using pair of herbs with ingredients of similar 
therapeutic actions, or by using a principal herb with main therapeutic actions and 
another one acting to enhance or assist the effects of the principle one. Mutual assistance 
can be achieved by using an herb that serves modulating roles such as treatment of 
accompanying symptoms, enhancement of pharmacokinetic properties, and 
harmonization etc.  Mutual restraint, suppression and antagonism can be achieved by 
using an herb with ingredients capable of moderation of harshness and toxicity of the 
ingredients of the principal herb. 
 
 While it is not yet possible to determine their molecular mechanisms, properties 
of TCM herb-pairs can be investigated to determine if they exhibit features consistent 
with their claimed unique synergistic combinations. By analyzing distribution patterns of 
the combination of TCM-HPs of these TCM herb-pairs, one may detect signs of herb-pair 
correlations that are expected to exist if these TCM herb-pairs have some form of synergy 
believed to be manifested in their TCM-HPs by TCM practitioners. Moreover, machine 
learning methods (MLMs) can be used to examine whether combinations of TCM-HPs of 
these TCM herb-pairs are truly distinguishable from those of non-TCM herb-pairs 
assembled by random combination of herb-pairs and by modification of known TCM 
herb-pairs that disrupts the presumed synergy. 
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 In this work, we analyzed the distribution profiles of the combination of TCM-
HPs of the 394 known TCM herb-pairs described in TCM literatures [Wang 2004] by 
using the same method as that for studying the profiles of TCM prescriptions [Ung et al. 
2006; Ung et al. 2007]. We also used three different MLMs to determine if the derived 
MLM classification systems can consistently distinguish TCM herb-pairs from the non-
TCM herb-pairs based on their TCM-HPs. Digitization of TCM-HPs was conducted by 
using the algorithm developed for clustering and classifying TCM prescriptions [Su 1997; 
Wang et al. 2005a]. The accuracy of these MLM classification systems was evaluated by 





3.2.1 Digital representation of herbs and herb pairs        
 
 TCM-HPs include five fundamental characters (cold, cool, neutral, warm and hot), 
five fundamental tastes (salty, sour, bitter, sweet and pungent), four toxic states (toxic, 
non-toxic, very toxic, and slightly toxic), and 12 meridians (Gui Jing) (bladder, spleen, 
large intestine, stomach, small intestine, liver, cardiovascular, heart, kidney, gallbladder, 
xin bao or pericardium and san jiao). TCM-HPs are thus divided into 4 classes: character 
(C), taste (T), meridian (M), and toxicity level (Tox) [Chan 1995b]. The class of C, T, M, 
and Tox can be further divided into 5, 5, 12, and 2 subclasses respectively, which along 
with the TCM-HPs in each subs-class are given in Table 3.1. For instance, the 12 
meridians are categorized into Yin and Yang sub-classes. The Yin sub-class contains 
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meridians of liver, heart, Xin Bao, spleen, lung, and kidney and the Yang sub-class 
includes meridians of bladder, small intestine, San Jiao, stomach, large intestine, and gall 
bladder.  
 
 As given in Table 2.3 from previous chapter, there are 11, 12, 12 and 4 TCM-HPs 
in the class of C, T, M and Tox respectively. These TCM-HPs form a vector h=(C, T, M, 
Tox) with a total of 11+12+12+4 =39 features to represent each herb. The value of a 
specific TCM-HP is 1 if the herb possesses the corresponding property, and it is 0 if the 
herb does not possess the property [Ung et al. 2006]. For a herb-pair composed of herb A 
and B, two separate vectors hAB = (CA, TA, MA, ToxA, CB, TB, MB, ToxB) and hBA = (CB, 
TB, MB, ToxB, CA, TA, MA, ToxA) of dimension 78 can be formed, both of which were 
used to represent that herb-pair.  
 
 For instance, the herb Ma Huang (Herba Ephedrae) has warm character, pungent 
and slight bitter taste, meridians for lung and bladder, and is non-toxic. The TCM-HPs 
for Ma Huang (Herba Ephedrae) are CA = (CA1, CA2, CA3, CA4, CA5, CA6, CA7, CA8, CA9, 
CA10, CA11) = (0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0), TA = (TA1, TA2, TA3, TA4, TA5, TA6, TA7, TA8, 
TA9, TA10, TA11, TA12) = (1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0), MA = (MA1, MA2, MA3, MA4, MA5, 
MA6, MA7, MA8, MA9,  MA10, MA11, MA12) = (1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0), ToxA = (TA1, 
TA2, TA3, TA4)=(0, 0, 0, 1). Herb Gui Zhi (Ramulus Cinnamomi) has warm character, 
pungent and sweet tastes, meridians for heart, lung and bladder, and is non-toxic. The 
TCM-HPs for Gui Zhi (Ramulus Cinnamomi) are CB = (CB1, CB2, CB3, CB4, CB5, CB6, CB7, 
CB8, CB9, CB10, CB11) = (0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0), TB = (TB1, TB2, TB3, TB4, TB5, TB6, 
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TB7, TB8, TB9, TB10, TB11, TB12) = (1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0), MB = (MB1, MB2, MB3, 
MB4, MB5, MB6, MB7, MB8, MB9,  MB10, MB11, MB12) = (1, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0), 
ToxB = (TB1, TB2, TB3, TB4)=(0, 0, 0, 1).  The herb pair composed of these two herbs can 
then be digitally represented by using two feature vectors hAB = (CA, TA, MA, ToxA, CB, 
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Table 3.1 List of Traditional Chinese Medicine herbal properties (TCM-HPs). These 
properties are classified into four classes, characters (Class C), tastes (Class T), meridians 
(Class M), and toxicity states (Class Tox). These are further divided into 5, 5, 2, and 2 
sub-classes for C, T, M and Tox respectively, each of which include 11, 12, 12, and 4 
TCM-HPs. The total number of unique TCM-HP vector for all TCM herbs is 
11+12+12+4 = 39.  
List of TCM herbal properties (TCM-HPs) 






















(4 in total) 
C1: Slightly 
cold 
T1:  Slightly 
salty 
M1: Liver  Tox1: 
Severely 
toxic 
M2: Heart  C2: Cold 








T2:  Salty 
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3.2.2 Selection of TCM herb-pairs and construction of non-TCM herb-pairs 
 
A total of 394 well established TCM herb-pairs were collected from a reputable 
TCM literature [Wang 2004], which are composed of 264 TCM herbs. The non-TCM 
herb-pairs were generated by two approaches, random combination of TCM herbs and 
modification of known TCM herb-pairs with disruption of their assumed synergy. In the 
first approach, a total of 635 commonly-used TCM herbs were divided into 23 
traditionally-defined therapeutic classes described in the TCM literature [Zhang 1998a]. 
For each therapeutic class, three herbs with TCM-HPs closest to the average values of 
herbs in the corresponding class were selected as the representative herbs for that class. 
These representative herbs were then randomly combined into pairs and subsequently 
checked to remove those matching the known TCM herb-pairs. This gave rise to 2,346 
herb-pairs which were tentatively used as non-TCM herb-pairs. In the second approach, 
existing TCM herb-pairs with knowledge of their “Master” herbs were modified by 
replacing the “Master” herbs with those possessing the opposite TCM-HPs to completely 
disrupt the expected synergy between the original “Master” herbs and the companion 
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3.2.3 Machine Learning Methods (MLMs) 
 
The detail algorithms of MLMs are described in Chapter 2 section 2.1.2.3. Only 
content relevant to the study of TCM herb pairs are described in further detail. 
3.2.3.1 Probabilistic Neural Network method (PNN) 
 
PNN is a form of neural network that uses Bayes optimal decision rule for 
classification [Specht 1990]. Traditional neural networks such as feed-forward back-
propagation neural network rely on multiple parameters and network architectures to be 
optimized. In contrast, PNN only has a single adjustable parameter, a smoothing factor σ 
for the radial basis function in the Parzen’s nonparameteric estimator. Thus the training 
process of PNN is usually orders of magnitude faster than those of the traditional neural 
networks.  
 
3.2.3.2 k Nearest Neighbor (kNN) 
 
For kNN a total of k vectors (representing k number of known TCM herb pairs 
and non-TCM herb pairs) nearest to the unclassified vector x are used to determine the 
class (TCM herb-pair class or non-TCM herb-pair class) of that unclassified vector (new 
herb pair). The class of the majority of the k nearest neighbors is chosen as the predicted 
class of the unclassified vector x.  
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3.2.3.3 Support Vector Machine (SVM) 
 
For SVM known TCM herb pairs and non-TCM herb pairs in a training set, 
represented by their TCM-HPs, are projected onto a hyperspace where they are separated 
by a hyperplane whose parameters are adjusted by using a separate testing set of TCM 
herb pairs and non-TCM herb pairs. By projecting the feature vector of a new multi-herb 
recipe onto this same hyperspace, this SVM system can be used to determine whether it is 
a valid TCM herb pairs based on its location with respect to the hyperplane.  
 
3.2.3.4 Methods for validating MLM classification systems 
 
To adequately assess the classification capability of the PNN, kNN and SVM 
classification systems developed in this work, two different evaluation methods were 
used. One is the 10-fold cross validation method, N-fold cross validation is one of the 
widely used methods for measuring the accuracies of MLM classification systems [Xue 
et al. 2004; Li et al. 2005a]. The other one is the use of external independent validation 
sets, which has been shown to be equally useful for evaluating the classification ability of 
MLM classification systems [Cai et al. 2003; Ung et al. 2006]. 
 
In using the 10-fold cross validation method, 394 TCM herb-pairs and 2470 non-
TCM herb-pairs were randomly divided into 10 subsets. Validation study can be 
conducted by using nine subsets as the training set and the remaining one as the testing 
set. Ten distinct combinations of training-testing sets can be generated from these 10 
subsets, and 10 iterations of validation studies were conducted. In using the independent 
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validation method, the 27 known forbidden herb-pairs from the 18-opposing-pairs (“shi 
ba fan”) and the 19-dislike-pairs (“shi jiu wei”) of TCM [Wang 2004] were used to test 
whether they can be predicted as non TCM herb-pairs. Moreover, a total of 1,065,100 
possible herb-pairs were generated from the 1,462 TCM herbs described in TCM 
literatures [Zhang 1998b; Hou 2001; Chen et al. 2002a] after elimination of the known 
TCM herb-pairs and the non-TCM herb-pairs used in our study, which were also used to 
test whether they can be predicted as non-TCM herb-pairs. 
 
3.2.3.5 Evaluating the Prediction Performance of Machine Learning Methods 
(MLMs) 
 
As in the case of all discriminative methods, the performance of MLMs can be 
evaluated by the quantity of true positive or TP (correctly classified TCM herb-pairs), 
true negative or TN (correctly classified non-TCM herb-pairs), false positive or FP (non-
TCM herb-pairs falsely classified as TCM herb-pairs), and false negative or FN (TCM 
herb-pairs falsely classified as non-TCM herb-pairs) respectively. Sensitivity (P+), 
SE=TP/(TP+FN) and specificity (P
-
), SP=TN/(TN+FP) are the prediction accuracy for 
TCM herb pairs and non-TCM herb pairs, respectively. The overall prediction accuracy 
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3.3 Results and Discussion 
 
3.3.1 Distribution patterns of TCM-HPs of TCM herb-pairs and their 
characteristics 
 
Based on the combination of their TCM-HPs, the 394 known TCM herb-pairs can 
be divided into three classes of predominantly warm, cold, and neutral characters 
respectively, which are given in Table 3.2. The “warm” class contains 6 groups of hot-
hot, warm-hot, warm-warm, hot-neutral, warm-neutral and warm-cool taste combinations. 
The “cold” class contains 7 classes of cold-cold, cold-cool, cool-cool, cold-neutral, cool-
neutral, cold-warm and cold-hot taste combinations. The “neutral” class contains 1 group 
of neutral-neutral taste combinations. Figure 3.1, Figure 3.1, and Figure 3.3 show the 
distribution patterns of the combination of TCM-HPs of the TCM herb-pairs in each of 
these classes. There a total of 25 possible combinations of character-character groups. 
Apart from the 14 groups described above, no known TCM herb-pairs belong to the other 
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Table 3.2 Distribution of 394 known TCM herb-pairs in different classes and groups 
defined by the combination of their TCM-HPs. 
 
TCM Herb-Pair Class TCM Herb-Pair Group Number of Herb Pairs 
Hot-Hot 4 
Hot-Warm 23 
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Figure 3.1 Distribution patterns of combinations of traditionally-defined herbal properties of TCM herb-pairs with predominantly warm characters. These 
herb-pairs are divided into hot-hot, warm-hot, warm-warm, hot-neutral, warm-neutral and warm-cool groups in decreasing order of warmness. The 
“warmer” pairs (hot-hot, warm-hot) primarily involve pungent-pungent, pungent-sweet, and sweet-sweet taste combinations. The “warm” pairs (warm-
warm) primarily involve pungent-pungent and pungent-bitter combinations. The “less warm” pairs (hot-neutral, warm-neutral and warm-cool) primarily 
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Figure 3.2 Distribution patterns of combinations of traditionally-defined herbal properties of TCM herb-pairs with predominantly cold characters. These 
herb-pairs are divided into cold-cold, cold-cool, cool-cool, cold-neutral, cool-neutral, cold-warm and cold-hot groups in decreasing order of coldness. The 
“extremely cold” pairs (cold-cold and cold-cool) primarily involve bitter-bitter taste combinations. The “colder” pairs (cool-cool) primarily involve bitter-
sweet, bitter-pungent, bitter-bitter, and pungent-sweet combinations. The “somewhat cold” pairs (neutral-cold and neutral-cool) primarily involve bitter-
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Figure 3.3 Distribution patterns of combinations of traditionally-defined herbal properties of TCM herb-pairs with predominantly neutral characters. The 
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3.2.3.2 Usefulness of TCM-HPs for distinguishing TCM herb-pairs from non-TCM 
herb-pairs 
 
A 10-fold cross validation study was conducted to determine whether the three 
machine learning methods (PNN, kNN and SVM) are able to separate TCM herb-pairs 
from non-TCM herb-pairs based on their TCM-HPs. The accuracies for predicting TCM 
herb-pairs are in the range of 72.1~87.9%, and those for predicting non-TCM herb-pairs 
are in the range of 91.6~97.6% respectively. The overall prediction accuracies range from 
91.1% to 94.9% and the Matthews correlation coefficients range from 0.694 to 0.781. 
These results suggest that TCM herb-pairs and non-TCM herb-pairs can be separated by 
MLMs based on their TCM-HPs.  
 
The developed MLM classification systems can be further tested to determine to 
what extent they are able to predict the following two groups of herb-pairs as non-TCM 
herb-pairs. One group contains the known non-TCM herb-pairs and the other includes 
vast number of the other possible herb-pairs not used as TCM herb-pairs and not used in 
our 10-fold cross validation studies. We found that 96.3% of the 27 known non-TCM 
herb pairs, and 99.7% of the other 1,065,100 possible herb-pairs were predicted as non-
TCM herb-pairs by the best performing MLM system SVM. These results suggest that 
our MLM systems are capable of dividing known TCM herb-pairs from known non-TCM 
herb-pairs and the vast number of other herb-pairs, and the TCM-HPs of the known TCM 
herb-pairs contain useful information for distinguishing them from the other herb-pairs.  
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3.4 Discussion and Conclusion 
 
The distribution patterns of combinations of the TCM-HPs of the majority of the 
394 herb-pairs appear to show some level of internal correlation. As shown in Figure 3.1, 
the “warmer” pairs (hot-hot, warm-hot) primarily involve pungent-pungent, pungent-
sweet, and sweet-sweet taste combinations. The “warm” pairs (warm-warm) primarily 
involve pungent-pungent and pungent-bitter combinations. The “less warm” pairs (hot-
neutral, warm-neutral and warm-cool) primarily involve sweet-sweet, sweet-pungent, and 
pungent-pungent combination. As shown in Figure 3.2, the “extremely cold” pairs (cold-
cold and cold-cool) primarily involve bitter-bitter taste combinations. The “colder” pairs 
(cool-cool) primarily involve bitter-sweet, bitter-pungent, bitter-bitter, and pungent-sweet 
combinations. The “somewhat cold” pairs (neutral-cold and neutral-cool) primarily 
involve bitter-sweet and sweet-sweet combinations. The “slightly cold” pairs (cold-warm 
and cold-hot) primarily involve bitter-pungent, bitter-sweet, and bitter-bitter 
combinations. From Figure 3.3, the neutral-neutral pairs were found to primarily involve 
sweet-sweet, sweet-salty, sweet-bitter, and sweet-sour taste combinations. 
 
These patterns of combinations have clinical relevance in prescribing TCM multi-
herb recipes. For instance, warm-warm herb-pairs such as Ma Huang (Herba Ephehrae) 
and Gui Zhi (Ramulus Cinnamomi), Gui Zhi (Ramulus Cinnamomi) and Chuan Xiong 
(Rhizoma Chuanxiong) have diaphoretic properties [Wang 2004] and have been used for 
treating exterior syndrome due to cold, promoting blood circulation, and tonics for 
internal warming [Wang 2004]. These symptoms have been described in TCM literatures 
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to be treated by herbs with warm characters and pungent and bitter tastes [Wang 2004]. 
Cold-cold herb-pairs such as Shi Gao (Gypsum Fibrosum) and Zhi Mu (Rhizoma 
Anemarrhenae) have been used for heat clearance, a symptom that requires herbs with 
cold characters and bitter tastes according to TCM theory [Li 2005]. Neutral-neutral 
herb-pairs such as Dang Shen (Radix Codonopsis) and Fu Ling (Poria) have been used as 
tonic in such mild conditions as diuresis and excreting dampness [Li 2005]. Herbs with 
neutral characters and sweet tastes are one of the main classes of herbs for treating these 
conditions in TCM literatures [Wang 2004].  
 
Herbs with opposite characters (such as warm-cold pair Gui Zhi (Ramulus 
Cinnamomi) and Shao Yao (Radix Paeoniae Alba), and hot-cold pair Fu Zi (Radix Aconiti 
Lateralis Preparata) and Da Huang (Radix et Rhizoma Rhei)) have been used for 
modulating the harsh effect of the companion herb or to complement its action. For 
instance, Fu Zi (Radix Aconiti Lateralis Preparata) is an herb with hot character and 
pungent taste that has been used for interior warming to cure serious Yang-deficient 
syndromes. Da Huang (Radix et Rhizoma Rhei), on the other hand, is an herb with cold 
character and bitter taste that has been used as a purgative herb for treating constipation 
associated to hotness symptoms and those exhibiting coldness in both hands and legs. 
When used together, both herbs not only modulate the harsh effects of each other but 
produce other synergistic effects. Fu Zi (Radix Aconiti Lateralis Preparata) produces 
lifting actions in the body to promote Qi and blood circulation. Da Huang (Radix et 
Rhizoma Rhei) produces descending actions to clear the hotness trapped in the 
gastrointestinal tracts.  
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Both distribution patterns of TCM-HPs and MLM classification studies show that 
TCM herb-pairs can be distinguished from non-TCM herb-pairs assembled by random 
combination of herbs and by modification of known TCM herb-pairs. Future work for 
elucidating the molecular mechanism of the synergistic actions of TCM herb-pairs is 
required. Knowledge of the molecular mechanism of these synergistic actions can 
facilitate the understanding of some aspects of the regulation of human physiological 
systems and the application of the principles of synergistic combinations of TCM herbs 
for developing novel cocktail therapeutic approaches to modulate and harmonize the 
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Chapter 4 Identification of Metastatic-Related Targets of 
Rhubarb Anthraquinones by an Inverse Docking Approach 
 
 
Metastasis is the fatal step in tumorigenesis. Proteins such as receptor tyrosine kinases, 
matrix metalloproteinases, cell adhesion molecules, small GTPases are identified as 
important mediators in cell invasion and motility in the process of metastasis. Previous 
experimental and proteomic works indicated that Rhubarb anthraquinones exhibit anti-
proliferative and anti-metastatic activity. However, the molecular targets and mechanism 
of anti-metastatic activity of these anthraquinones are poorly understood. In this chapter, 
an in silico inverse docking approach is utilized to identify putative metastatic-related 
molecular targets of Rhubarb anthraquinones emodin, aloe-emodin, and rhein from a 
protein structure database. The identified molecular targets are then compared with 





Rhubarb root (Da Huang) is one of the commonly used Chinese herbs. The most 
commonly used species is Rheum palmatum or Rheum officinale Baill of the 
Polygonaceae family. Rhubarb is traditionally used as a laxative, in treatment of 
constipation jaundice, gastro-intestinal hemorrhage, and ulcers. The main bioactive 
constituents of rhubarb are anthraquinone derivatives, including emodin, aloe-emodin, 
rhein, chrysophanol, physcion, and danthron. In addition, catechins, gallic acid, and 
cinnamic acid are also present in rhubarb. 
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A number of studies have demonstrated that the main anthraquinones of rhubarb, 
emodin, aloe-emodin, and rhein, inhibit the growth and proliferation of various cancer 
cells. For instance, emodin has been reported to inhibit proliferation in breast cancer cells 
[Zhang et al. 1995; Zhang et al. 1999], lung [Su et al. 2005], cervical [Srinivas et al. 
2003], and prostate cancers cells [Cha et al. 2005]. Aloe-emodin was also able to inhibit 
cell growth in several tumor cells, including human lung carcinoma [Lee et al. 2006], 
hepatoma [Kuo et al. 2002], and leukemia cell lines [Chen et al. 2004]. Rhein, another 
anthraquinone derivative of rhubarb, has also been reported to display inhibitory effect on 
the proliferation of human breast, colon, lung, CNS, and glioma cancer cells [Cichewicz 
et al. 2004]. Effect of the main rhubarb anthraquinones, emodin and aloe-emodin on 
G2/M cell cycle have been demonstrated on various cancer cells, including v-ras-
transformed cells, hepatoma, leukemia, and neuroectodermal cells [Chan et al. 1993; 
Chen et al. 2004; Xiao et al. 2007].  
 
In addition to anti-proliferative activity, a number of studies have demonstrated 
that emodin is capable of inducing apoptotic cell death in various cancer cells [Shieh et al. 
2004]. Several studies indicate that emodin-induced apoptosis is mediated by ROS 
generated from the semiquinone. Similar to emodin, apoptosis can be induced by aloe-
emodin in various tumor cells. Aloe-emodin can induce sub-G1 peak (one of the 
biomarkers of apoptosis) at 48 hr following G2/M arrest at 24 hr in neuroectodermal 
tumor cells. Aloe-emodin was also found to induce apoptosis in many other tumor cells 
derived from hepatoma, lung, bladder carcinoma, and leukemia. Similar to emodin, aloe-
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emodin can induce DNA damage through oxidative stress, and later initiate apoptosis 
[Lin et al. 2006]. In addition, aloe-emodin-induced apoptosis in HepG2 cells was found 
to be ROS-dependent [Lu et al. 2007]. Rhein, another Rhubarb anthraquinone was shown 
to induce apoptosis in HL-60 cells through the mitochondrial death pathway by causing 
the loss of mitochondrial membrane potential, cytochrome c release, and cleavage of Bid 
protein [Lin et al. 2003]. Taken together, these results suggest that anthraquinones 
(emodin, aloe-emodin, and rhein) activate apoptotic cell death in different tumor cells and 
the mitochondrial-dependent pathway was suggested to be the main apoptotic process. 
 
The lethality of cancers is caused by the metastatic spread of tumor cells from 
their original site. The metastasis events include angiogenesis, cell adhesion, cell invasion 
(extracellular matrix degradation and cell migration), and cell proliferation. One critical 
aspect of the anti-cancer activity of Rhubarb anthraquinones is their inhibitory effect on 
cancer metastasis. Emodin inhibits TNF-α-induced expression of cell surface adhesion 
proteins (ICAM-1, VCAM-1, ELAM-1), which is essential in cell adhesion, migration, 
and inflammation [Kumar et al. 1998] that is mainly due to suppression of emodin on 
NF-kB activation [Li et al. 2005b]. Emodin was found to exhibit significant inhibition on 
the adhesion of various cancer cells [Kim et al. 2005; Huang et al. 2006c]. Emodin 
reduces cholesterol content in the membrane lipid rafts, preventing rafts clustering and 
subsequent colocalization of integrin β1 and focal adhesion complex proteins, and 
eventually disrupting the lipid rafts-associated integrin-signaling pathway [Huang et al. 
2006c]. In addition, emodin inhibits EGF-induced cell migration in various cancer cells. 
PI3K was found to be the molecular target for emodin and significantly suppressed the 
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PI3K-mediated Cdc42 and Rac1 activation and subsequent cytoskeletal changes, 
including filopodia and lamellipodia formation [Huang et al. 2006b]. Emodin also 
inhibits the invasion of human cancer cells by suppressing MMP-9 expression via 
inhibiting AP-1 and NF-kB signaling pathways [Kim et al. 2005]. Less study was 
conducted on rhein, some related reports implicated that rhein might have certain 
inhibiting effects in the cascade of tumor metastasis such as via the suppression of IL-1α-
induced production of pro-MMPs [Sanchez et al. 2003]. 
  
Recent proteomic study by Lu and coworkers suggests that up-regulation of 
nucleoside diphosphate kinase A or nm23 (a metastasis suppressor gene) by aloe-emodin 
decreased cell migration [Lu et al. 2007]. Due to the difference in anti-metastatic activity 
of Rhubarb anthraquinones emodin and aloe-emodin, it is necessary to identify their 
potential metastatic-related targets and to unravel their mechanism. Understanding the 
molecular mechanisms of the anti-metastatic activities of these compounds can help to 
further refine not only molecular specificity but inhibition of metastasis process at 
different stages. Besides, the metastatic-related molecular targets of rhein are also worth 
exploring. 
 
In this study, an in silico approach inverse docking method (INVDOCK) has been 
used to search the potential metastatic-related targets of Rhubarb anthraquinones emodin, 
aloe-emodin, and rhein. As opposed to conventional docking strategy where one protein 
target is searched against a compound library for potential drug candidates, INVDOCK 
was designed to facilitate identification of molecular targets of a compound from a 
protein structure database. INVDOCK had been shown to be able to identify known 
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protein targets of some well known pharmaceutics such as aspirin and tamoxifen [Chen et 
al. 2002b; Chen et al. 2003]. In addition, INVDOCK had been applied to identify 
therapeutic and toxicity targets of some herbal compounds from previous studies [Chen et 




4.2.1 The Algorithm of INVDOCK 
 
For a conventional docking approach, a protein is searched against compounds 
from a chemical library to identify potential ligands of the protein. However, INVDOCK 
is based on a protein-ligand inverse docking strategy such that a compound is docked to 
known ligand-binding pockets of each protein in a protein 3D structural database such as 
the Protein Data Bank (PDB). A protein is considered as a potential target for a 
compound if that compound can be docked into the protein and the binding satisfies a 
molecular-mechanics based criterion for chemical complementarity.  
 
To facilitate a high-speed search of potential protein targets of a compound, a 
protein cavity database has been developed from the corresponding protein 3D structures 
in the PDB. Each cavity entry is composed of a sphere cluster filling the cavity [Shoichet 
et al. 1991]. Each PDB entry has a corresponding cavity entry in cavity database. 
Docking of a compound is performed against each cavity entry in the cavity database to 
identify cavities that can be successfully docked to a compound.  
 
CHAPTER 4 INVERSE DOCKING 60 
Docking of a particular compound to a cavity is by the following steps. The 
compound is first aligned within the selected site by matching the position of each atom 
of the compound with the center of the spheres. Because of the relatively low-resolution 
nature of the conformation sampling of the compound, a certain degree of structural clash 
is allowed at this stage. Optimization is then conducted by a limited torsion space 
sampling of rotatable bonds in the structure and those in the side-chain of the receptor 
amino acid residues at the binding site. Each rotatable bond is sampled in the range of 
±15 degree followed by 50 iterations of Cartesian coordinate energy minimization on all 
chemical and protein atoms at the binding site to further optimize the protein-ligand 
complex. The steepest descent method is used for energy minimization. In both torsion 
optimization and energy minimization, AMBER force fields [Case et al. 2005] are used 
for terms of covalent bond, bond angle, torsion, and non-bonded van der Waals and 
electrostatic interactions. Morse potential which is a function of donor-acceptor distance 
is used to represent hydrogen bond terms.  
 

































In this function, R, θ, and ф denote bond length, bond angle, and torsion angle 
respectively; values for Req, θeq and eqφ  are from the original PDB structure and the 
structure of the drug and taken as equilibrium bond length, bond angle, and torsion angle, 
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respectively. Kr and Kө are covalent and bond angle bending force constant, respectively. 
Vn and n are torsion parameters; and r is the distance of hydrogen bond donor-acceptor. 
Vo, a, and ro are parameters for hydrogen bond potential. Scoring of docked molecules is 
based on a protein-ligand interaction energy function ∆ELP composed of the same 
hydrogen bond and non-bonded terms as used for structure optimization. Analysis of a 
large number of PDB ligand-protein complexes shows that the computed ∆ELP is 
generally below ∆EThreshold = αN kcal mol-1, where N is the number of ligand atoms and α 
is a constant ~1.0. The exact value of α can be determined by fitting the linear equation 
∆EThreshold  = -αN to the computed ∆ELP for a large set of PDB structures. The statistically 
derived energy value can be used empirically as a threshold to screen for potential ligands. 
A polynomial form of ∆EThreshold involving more parameters can be introduced to derive 
an energy threshold. ∆ELP can be required to be lower than ∆EThreshold when selecting 
successfully docked structures.  
 
Since drug binding is competitive in nature, a drug is unlikely to be effective if it 
binds weakly to a protein target compared to its natural ligand. Ligands in PDB structures 
are known binders. Therefore PDB ligands bound to the same receptor site as that of a 
docked molecule may be considered as “competitors” of that molecule. To select a 
putative protein target using INVDOCK, the computed ∆ELP is not only evaluated against 
∆EThreshold but also compared to the protein-ligand interaction energy of the corresponding 
PDB ligands that bind to the same cavity in this or other relevant PDB entries. The 
protein-ligand interaction energy for the relevant PDB structures is computed by the same 
energy functions as that for the docked molecule. In addition, the value of ∆ELP of a 
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docked molecule is required to be lower (more stable) than a “competitor” energy 
threshold ∆ECompetitor when selecting a putative target. ∆ECompetitor can be taken as the 
highest ligand-protein interaction energy of the corresponding PDB ligands multiplied by 
a factor β. In order to be able to find weak binders as well as strong binders, a factor β ≤ 1 
is introduced to scale the protein-ligand interaction energy of PDB ligand since a weak 
binder may have slightly higher interaction energy than that of a PDB binder. No 
experimental data have been found to determine the value of β. Hence β has been 
tentatively determined by an analysis of the computed energy for a number of compounds. 
A value of 0.8 for β statistically is enough to produce reasonable results. 
 
4.2.2 Validation of INVDOCK Results on Targets of Rhubarb Anthraquinones 
 
 
The validation for INVDOCK prediction on the targets of synthetic chemicals had 
been conducted from a recent study on a number of clinical agents [Chen et al. 2002b; 
Chen et al. 2003]. In this study, the targets of Rhubarb anthraquinones such as emodin, 
aloe-emodin, and rhein identified by INVDOCK were validated with known reported 
targets identified from various experimental works. The INVDOCK-generated “docked” 
structures of Rhubarb anthraquinones were generated for visual inspection to identify 
putative binding residues around the binding sites. These “key residues” may serve for 













 Molecular targets of Rhubarb anthraquinones emodin, aloe-emodin, and rhein 
identified from various experimental works are used to validate the efficiency of the 
ability of INVDOCK to pick up known targets from structural-based criteria. Table 4.1, 
Table 4.2, and Table 4.3 show the comparison of experimental verified targets and 
INVDOCK-identified targets denoted in PDB ID for emodin, aloe-emodin, and rhein, 
respectively. Since emodin is well studied than aloe-emodin and rhein, more known 
targets are available to verify the efficiency of INVDOCK for this compound. Overall, 
INVDOCK is able to identify a number of known targets of Rhubarb anthraquinones 
from a protein structure database. Figures 4.1 to Figure 4.4 show some representatives 
of INVDOCK-generated docked anthraquinone-protein complexes for kinases that 
involved in metastatic-related signaling pathways and metastatic-related targets that are 
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Table 4.1 Targets of emodin from biochemical studies and from INVDOCK denoted in 
PDB ID. Binding energy in kcal/mol for each target is given. 
 
Targets of emodin Effects of emodin 






Focal Adhesion Kinase 
(FAK), a key regulator 
of cell adhesion and 
migration 
 
Inhibit the association of 
FAK with integrin β1 
and decrease in the 
phosphorylation level of 
FAK-Tyr397 in a time-
dependent manner 
Huang et al, 2006 
(16740720) 
1mp8 [-41.1] (human) 
Phosphatidylinositol 3-
Kinase (PI3K), involves 
in cell mobility 
Suppress PI3K-
Cdc42/Rac1 pathway 
leading to decreased cell 
mobility 
Huang et al, 2005 
(15928809) 
2a98 [-39.4] (human), 
1w2d [-46.6] (human) 
Cdc42, involves in cell 
mobility 
Interfere the formation 
of the Cdc42/Rac1 and 
PAK1 complex 
Huang et al, 2005 
(15928809) 
1u4d [-45.4] (human), 
1u54 [-48.2] (human) 
Rac1, involves in cell 
mobility 
Interfere the formation 
of the Cdc42/Rac1 and 
PAK1 complex 
Huang et al, 2005 
(15928809) 
None 
NF-κB, an important 
transcription factor 
involves in MMP-9 
expression 
Inhibit the binding to 
DNA in a dose-
dependent manner 
Huang et al, 2004 
(15194008) 
1lei [-56.7] (mouse) 
Activator Protein-1 (AP-
1), an important 
transcription factor 
involves in MMP-9 
expression 
Reduce transcription 
activity of AP-1 




















Factor Receptor (EGFR) 
Inhibits epidermal 
growth factor (EGF)- 
induced migration in 
various human cancer 
cell lines 
Huang et al, 2005 
(15928809) 
None 
Protein Tyrosine Protein 
Kinases 
 Zhang and Hung, 1996; 
Chan et al, 1994 
1bbz [-39.2] (human 
ABL tyrosine kinase), 
1qpj [-41.5] (human 
LCK tyrosine kinase) 
p56lck  Jayasuriya et al, 1992 1qpe (human), 1qpj 
(human), 1qpc (human) 
Cyclin, Cyclin-
Dependent Protein 
Suppressing cyclin D1 
and E expression and 
Kwak et al, 2006 1dm2 [-45.0] (human), 
1unh [-45.0] (human), 
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1unl [-42.6] (human) 
SARS-CoV spike (S) 
protein 
blocks the SARS-CoV 
spike (S) protein and 
ACE2 interaction in a 
dose-dependent manner 





blocks the SARS-CoV 
spike (S) protein and 
ACE2 interaction in a 
dose-dependent manner 
Ho et al, 2006 
(16730806) 
1o86 [-40.1] (human) 
DNA Interacts with DNA by 
intercalating into the 
double helix of DNA 
Wang et al, 2006 324d [-52.4] 
K-ATP Channel, Na+-
K+-ATPase 
Inhibit the activity of 
KATP channel in the 
guinea pig taenia coli 
smooth muscle cells; 
Emodin enhances the 
function of small 
intestinal peristalsis of 
mice by mechanisms of 
promoting secretion of 
motilin, lowering the 
content of somatostatin 
and inhibiting Na+-K+-
ATPase activity of small 
intestinal mucosa 
Li et al, 1998 
(12016996); Zhang ey 




Induces apoptosis in 
human 
promyeloleukemic HL-
60 cells accompanied by 
activation of caspase 3 
cascade; Emodin 
generated reactive 
oxygen species (ROS) in 
these cells which 
brought about a 





by the activation of 
caspase-9 and caspase-3, 
leading to DNA 
fragmentation and 
apoptosis 
Chen et al, 2002 




1nme [-43.2] (human), 
1rhm [-41.7] (human) 
Protein Kinase C, CREB Suppressing PKC 
activation and CREB 
phosphorylation 
Chan et al, 2003 None 
Androgen Receptor Decreased the 
association of androgen 
receptor (AR) and heat 
shock protein 90 and 
increased the association 
Cha et al, 2005 1t74 [-40.0] 
(Chimpanzee),  
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of AR and MDM2 
Fatty Acid Synthase 
(FAS) 
Emodin inhibits cell 
differentiation into 
adipocyte and is a 
potential to serve as a 
fat-reducing drug 
Zhang et al, 2002 
(12150738) 
None 
Receptor-2 (KDR/Flk-1) Inhibitory effect of 
emodin toward VEGF-
A-induced angiogenesis 
in vitro and responsible 
for its potent anti-
angiogenic in vivo 
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Table 4.2 Targets of aloe-emodin from biochemical studies and from INVDOCK 












H(1) receptor Aloe emodin is proposed 
to bind to H(1) receptor 
and stimulates mast cells 
within the colonic mucosa 
to release histamine 






apoptosis of H460 cells 
involves modulation of 
cAMP-dependent protein 
kinase, protein kinase C, 
Bcl-2, caspase-3 and p38 
protein expression 
Yeh et al, 2003 
(12794753) 
1stc [-48.8] (bovine)  
Protein Kinase C Aloe-emodin induces 
apoptosis of H460 cells 
involves modulation of 
cAMP-dependent protein 
kinase, protein kinase C, 
Bcl-2, caspase-3 and p38 
protein expression 
Yeh et al, 2003 
(12794753) 
None 
Bcl-2 Aloe-emodin induces 
apoptosis of H460 cells 
involves modulation of 
cAMP-dependent protein 
kinase, protein kinase C, 
Bcl-2, caspase-3 and p38 
protein expression 
Yeh et al, 2003 
(12794753) 
None 
Caspase-3 Aloe-emodin induces 
apoptosis of H460 cells 
involves modulation of 
cAMP-dependent protein 
kinase, protein kinase C, 
Bcl-2, caspase-3 and p38 
protein expression 
Yeh et al, 2003 
(12794753); Chen et al, 
2004 (15207375); Lian et 




p38 Aloe-emodin induces 
apoptosis of H460 cells 
involves modulation of 
cAMP-dependent protein 
kinase, protein kinase C, 
Bcl-2, caspase-3 and p38 
protein expression 
Yeh et al, 2003 
(12794753) 
1bl7 [-61.6], 1di9 [-




Aloe-emodin displays a 
dose-dependent inhibition 
to cytosolic NAT activity 
and intact mice leukemia 
cells 
Chung et al, 2003 
(12804642); Lin et al, 
2005 (16314733) 
None 
DNA Binds to DNA and induces 
apoptosis 
Pecere et al, 2003 
(12918060) 
None 
Inducible Nitric Oxide Aloe-emodin modulates Mijatovic et al, 2004 4nos [-44.4] 
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Synthase (NOS) survival of mouse L929 
fibrosarcoma and rat C6 
astrocytoma cells through 
interference with the 
activation of inducible 
nitric oxide synthase 
(NOS) and subsequent 
production of tumoricidal 
free radical NO 
(15241556) (human) 
Extracellular Signal-
Regulated Kinases 1 and 
2 (ERK1/2) 
Aloe-emodin inhibits the 
activation of extracellular 
signal-regulated kinases 1 
and 2 (ERK1/2) in C6 
cells 
Mijatovic et al, 2005 
(15747063, 15905960) 
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Table 4.3 Targets of Rhein from biochemical studies and from INVDOCK denoted in 
PDB ID. 
 





IL-1beta potent inhibitor of IL-




Pelletier et al, 1998 
(9858439); Yaron et al, 
1999 (10329302) 






production of proMMPs 
and up-regulates the 
tissue inhibitors of 
metalloproteinase-1 
(TIMP-1) production 
Tamura et al, 2001 
(11300749) 
1jap [-59.9], 1g49 [-
59.2], 966c [-62.6] 
(human) 
GLUT1 Down-regulates the 
expression of glucose 
transporter-1 (GLUT1) 
mRNA and glucose 
uptake in mesangial 
cells 
Zhang et al, 1999 
(11721442) 
None 
TGF-beta1 hepatoprotective via 
antioxidant and anti-
inflammatory activity 
Guo et al, 2002 
(12147197) 
None 
Nuclear factor-kappaB inhibits nuclear factor-
kappaB activation and 
the expression of 
nuclear factor-kappaB-
dependent genes, such 
as the inducible nitric 




Mendes et al, 2002 
(12193257) 





Tegos et al, 2002 
(12234835) 
1mv5 [-53.2], 2bow [-
39.0] (bacterial) 
Inducible nitric oxide 
synthase 
Inhibitor of inducible 
nitric oxide synthase 
leading to anti-
inflammation effects 
Wang et al, 2002 
(12391547) 
4nos [-51.6] (human) 
Activator protein-1 (AP-
1) 
anti-carcinogenesis Lin et al, 2003 
(12632075) 
None 
c-Jun inhibits the 
phosphorylation and 
abundance of c-Jun 
protein, c-Jun NH2-
terminal kinase (JNK) 
phosphorylation 







overexpression of PAI-1 
for the treatment of 
Zhu et al, 2003 
(12781036) 
None 
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vascular diseases 
TGFbeta1 inhibits the proliferation 
of human mesangial 
cells (HMCs) may 
through inhibiting the 
bioactivities of 
TGFbeta1 and p38 
MAPK 
Tan et al, 2004 
(15696926) 
None 
p38 inhibits the proliferation 
of human mesangial 
cells (HMCs) may 
through inhibiting the 
bioactivities of 
TGFbeta1 and p38 
MAPK 
Tan et al, 2004 
(15696926) 
1bl7 [-50.0], 1di9 [-
46.3] (human) 
Human serum albumin 
(HSA) 
 Li et al, 2007 
(17174615) 
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Figure 4.1 Examples of INVDOCK-generated binding of emodin to kinases involve in 
metastatic-related signaling pathways. The molecule of emodin is represented as space-
filled model. The binding energy in kcal/mol is given.  
 
(a) Binding of emodin to human focal 
adhesion kinase 1 (PDB ID: 1mp8 [-41.1]) 
 
 
(b) Binding of emodin to human FGF 
Receptor 1 (PDB ID: 1fgi [-47.6]) 
 
 
(c) Binding of emodin to human LCK 
kinase (PDB ID: 1qpe [-39.8]) 
 
 
(d) Binding of emodin to human activated 
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Figure 4.2 Examples of INVDOCK-generated binding of emodin to metastasic-related 
targets that involve in cell adhesion, cytoskeleton, and cell motility. The molecule of 
emodin is represented as space-filled model. The binding energy in kcal/mol is given.  
 
(a) Binding of emodin to human MMP-1 
(PDB ID: 966c [-67.9]) 
 
 
(b) Binding of emodin to human cathepsin 
F (PDB ID: 1m6d [-42.7]) 
 
 
(c) Binding of emodin to human actin 
(PDB ID: 1nm1 [-41.3]) 
 
 
(d) Binding of emodin to human 









CHAPTER 4 INVERSE DOCKING 73 
Figure 4.3 Examples of INVDOCK-generated binding of aloe-emodin to kinases involve 
in metastatic-related signaling pathways. The molecule of aloe-emodin is represented as 
space-filled model. The binding energy in kcal/mol is given. 
 
(a) Binding of aloe-emodin to human 
proto-oncogene tyrosine-protein kinase Src 
(PDB ID: 1yol [-48.9]) 
 
 
(b) Binding of aloe-emodin to human FGF 
receptor 1 (PDB ID: 1agw [-45.2]) 
 
 
(c) Binding of aloe-emodin to human LCK 
kinase (PDB ID: 1qpe [-40.7]) 
 
 
(d) Binding of aloe-emodin to rat 
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Figure 4.4 Examples of INVDOCK-generated binding of aloe-emodin to metastasic-
related targets that involve in cell adhesion, cytoskeleton, and cell motility. The molecule 
of aloe-emodin is represented as space-filled model. 
 
(a) Binding of aloe-emodin to human 




(b) Binding of aloe-emodin to human 






(c) Binding of aloe-emodin to human 
cathepsin S (PDB ID: 2f1g [-45.2]) 
 
 
(d) Binding of aloe-emodin to human 
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Metastasis is a wide range process that involves cell-cell adhesion, regulation of 
cytoskeleton, cell signaling in survival and proliferation, angiogenesis, and cell migration. 
Hence, a wide range of important proteins mediate in these processes play an important 
role in regulating the fidelity of metastagenecity. These proteins include receptor tyrosine 
kinases such as epidermal growth factor receptor (EGFR) that serve as in initiating the 
early event of metastatic-related pathways, small GTPases such as RhoA and Rac1 that 
regulate formation of cytoskeleton, proteinases such as matrix metalloproteinases (MMPs) 
that involve in detachment of cell adhesion and migration, angiotensin-converting 
enzymes (ACE), cell adhesion molecules (CAM) that mediate cell-cell adhesion, and 
prostaglandin synthesizing enzymes such as cyclooxygenase 2 (COX2).  
 
The metastatic-related targets of emodin, aloe-emodin, and rhein identified from 
INVDOCK search were listed and compared with previous experimental works in Table 
4.4. Results from both experimental works and INVDOCK implicate that emodin and 
aloe-emodin are more potent in their anti-metastasis activity than rhein. Although less 
works had been done on rhein, less metastatic-related targets identified from INVDOCK 
search implicates that rhein is less effective in inhibiting metastasis process. However, as 
shown in Table 4.4, rhein may be most effective in the stage of reducing cell detachment 
as it inhibits the activity of MMPs. Table 4.4 shows that both emodin and aloe-emodin 
exhibit the anti-metastatic activity at various stages of metastasis process.  
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Table 4.4 Involvement of selected Rhubarb anthraquinones (emodin, aloe-emodin, rhein) 
in different stages of anti-metastatic processe as compared from both experimental 
findings as denoted in Pubmed ID and INVDOCK results as denoted in PDB ID. Exp: 
Experimental, INV: INVDOCK results, None: No report on a particular target for a given 
Rhubarb anthraquinone implicates insufficient studies performed or no result from 
INVDOCK. 
 
Involvement of selected Rhubarb anthraquinones in 
different stages of metastatic process 
 
Emodin Aloe-Emodin Rhein 
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Activator Protein-1 (AP-1) 15194008 None None None 12632075 None 
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Recent experimental works suggested that aloe-emodin is more cytotoxic and 
more effective in inducing apoptosis than emodin [Lu et al. 2007]. In addition, proteomic 
study showed that aloe-emodin was able to decrease cell migration via up-regulating 
nm23 a metastasis suppressor gene [Lu et al. 2007]. Experimental works indicate that 
nuclear receptors such as retinoic acid receptor (RAR), estrogen receptor (ER), and 
glucocorticoid receptor (GR) up-regulate and nuclear receptor such as thyroid hormone 
receptor (THR) down-regulate the expression of nm23 (Table 4.5). So far there is no 
experimental works done to explore the effect of Rhubarb anthraquinones on nuclear 
receptors towards nm23 expression and activity. Results from INVDOCK suggest that 
both emodin and aloe-emodin bind to these nuclear receptors implicating that these 
anthraquinones affect gene expression regulated by these nuclear receptor. In contrast, 
rhein only binds to estrogen receptor as suggested from INVDOCK search. 
 
A ligand that binds competitively to the enzyme active site is most likely 
behaving as a competitive inhibitor of the enzyme. However, the ability of Rhubarb 
anthraquinones to bind to the ligand binding domain (LBD) of a nuclear receptor does not 
directly implicate their agonism or antagonism towards this receptor. Both agonists and 
antagonists are known to bind to LBD of nuclear receptors but at different binding modes 
culminating in recruiting coactivators or coreprressors, respectively. Crystallography 
works by Brzozowski and coworkers on estrogen receptor α (ERα) showed that the 
antagonist raloxifene induced repositioning of helix 12 of ERα that involved rotation of 
130 degree combined with a 10-angstrom rigid-body shift towards N-terminus of the 
LBD as compared to the conformation induced by the agonist 17β-estradiol [Brzozowski 
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et al. 1997]. Thus, the agonism or antagonism of Rhubarb anthraquinones to these 
nuclear receptors to the expression of nm23 as identified from INVDOCK search remain 
for further experimental validation. Indeed, emodin was shown to act as a phytoestrogen 
while aloe-emodin acts as weaker phytoestrogen that competes the binding with natural 
estrogen 17β-estradiol for LBD of estrogen receptor [Matsuda et al. 2001] suggesting the 
capability of these anthraquinones in elevating the expression of nm23. Besides, emodin 
was shown to inhibit the growth of prostate cancer cells via down-regulating androgen 
receptor [Cha et al. 2005]. As shown in Table 4.5 the capability of emodin and aloe-
emodin in regulating the expression of nm23 via androgen receptor remain for future 
works.  
 
Among these nuclear receptors, thyroid hormone receptor (THR) was shown to 
reduce the expression of nm23 [Lin et al. 2000]. Only anthraquinone aloe-emodin binds 
to LBD of THR as identified from INVDOCK search. As the cellular work on the human 
hepatoma HepG2 suggested that aloe-emodin but not emodin induce expression of nm23 
[Lu et al. 2007] the antagonism of aloe-emodin towards THR on HepG2 cell remain for 
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Table 4.5 Involvement of selected Rhubarb anthraquinones (emodin, aloe-emodin, rhein) 
in regulating the expression and activity of metastatic suppressor gene nm23 via binding 






4.4.1 Metastatic-related targets of Rhubarb Anthraquinone Emodin, Aloe-Emodin, 
and Rhein identified from INVDOCK search 
 
The lethality of metastatic spread of tumor cells from their original site include 
angiogenesis, cell adhesion, cell invasion (extracellular matrix degradation and cell 
Status of INVDOCK-generated results Nuclear Receptors Effect of receptor 
agonists to nm23 
activity or expression Emodin Aloe-Emodin 
Rhein 
Orphan nuclear receptor 
retinoid Z receptor β 
(RZRβ) 
Interacts with nm23-2 
[8858107] 
None None None 
Retinoic acid related 
orphan receptor α (RORα) 
Interacts with nm23-2 
[8858107]  
None None None 
Retinoic acid receptor 
(RAR) 






2nll (human) None 
















Thyroid hormone receptor 
(THR) 












Bile acid receptor Remain for further 
investigations 
1ot7 (rat) 1ot7, 1osv 
(rat) 
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Retinoid X receptor 
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migration), and cell proliferation. These processes involve myriad of cell signaling 
pathways, regulation of cytoskeleton and cell motility. Recent work from Massague’s 
group using microarray data showed that EGFR, epiregulin, MMP1, MMP2, and COX2 
are essential to mediate breast cancer metastasis in lung [Minn et al. 2005]. Their 
subsequent work using different combinations of drugs that target these proteins showed 
either additive or synergistic effects to inhibit the spread of metastatic breast cancer cells 
in mice [Gupta et al. 2007]. As Rhubarb anthraquinones target to EGFR, MMP1, MMP2, 
and COX2 as implicated from INVDOCK search (Table 4.4), this implicates that 
Rhubarb anthraquinones such as emodin, aloe-emodin, and rhein possess either additive 
or synergistic effects in inhibiting metastasis of cancer cells when used in combinations. 
The clinical values of these anthraquinones in anti-metastasis remain for future 
investigations. 
 
Aloe-emodin but not emodin was shown to up-regulate a metastasis suppressor 
gene nm23 in human HepG2 carcinoma cells. However, the dependence of nm23 up-
regulation by Rhubarb anthraquinones on the aspect of cellular context remained for 
further works. Agents that are known to elevate nm23 expression interact with nuclear 
hormone receptors including RAR, ER, and GR [Ouatas et al. 2003]. The estrogen E2 
acts through estrogen receptor α (ERα) via a positive estrogen-responsive element (ERE) 
in the promoter region of the nm23-H1 gene [Lin et al. 2002]. However, binding of 
thyroid hormone receptor (THR) by thyroid hormone reduces the elevation of nm23 [Lin 
et al. 2000]. The thyroid hormone T3 acts through THR inhibiting the transcription of 
nm23-H1 via binding to a negative regulatory element in the promoter region of the gene 
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[Lin et al. 2000]. This suggests that T3 promotes tumor metastasis by down-regulating 
the expression of metastasis suppressor gene nm23-H1. INVDOCK results suggest that 
only aloe-emodin binds to THR (Table 4.5) showing the difference of emodin and aloe-
emodin in their anti-metastatic activities. However, the antagonism of aloe-emodin on 
THR in HepG2 cells remains to work out. 
 
4.4.2 Limitations and future improvement of INVDOCK and plans to incorporate 
INVDOCK results with experimental works 
 
The discrepancy between the INVDOCK results and available experimental data 
arises due to a number of reasons. It is not expected that exhaustive experiments have 
been performed to determine all protein targets of Rhubarb anthraquinones. The lack of 
sufficient experimental data is likely to be an important factor for the discrepancy. 
Another source of discrepancy is the lack of relevant protein structures. A large number 
of known membrane-bound therapeutic targets especially G protein-coupled receptors 
(GPCRs) are not available. In addition, some entries in protein structure database may be 
of little relevance such as entries containing incomplete sections or chains. “False hits” 
may thus be generated if these irrelevant structures are selected by INVDOCK. Progress 
in structural genomics is expected to provide a more diverse set of relevant structures. 
Besides, studies of protein function facilitate the selection of potential protein targets 
related to a particular cellular or physiological condition. In addition, incorporation of 
proteomics data in term of cellular context and gene expression profiles is expected to 
improve the performance of INVDOCK.  
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Exhaustive search to find optimum binding modes of Rhubarb anthraquinones to 
their targets are not conducted due to heavy computational load as all protein cavities in 
the PDB are used. However, the docked structures from INVDOCK are sufficient to 
identify putative binding residues. Alanine scanning can then be applied to protein 
regions that cover the contacting residues for Rhubarb anthraquinones to further explore 
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Chapter 5 The Study of Molecular Mechanism of Synergistic 
Effects in Herbal Ingredients 
 
There have been different views about the therapeutic efficacy of herbal supplements and 
medicinal herbs. Their use in therapeutics is primarily based on the hypothesis that 
multiple ingredients are better than one. The reported efficacy of certain herbs at 
apparently lower doses of active constituents suggests a need for molecular study to 
determine whether the efficacy is due to placebo or synergistic effects. Knowledge of 
synergism in some herbs, if confirmed, may be further explored for developing novel 
cock-tail therapeutics. This chapter provides in-depth and comprehensive analyses of 
lessons learned from rigorous molecular study of clinical combinations of drug-drug 
interactions to exhibit molecular interaction profiles likely contributing to herbal 
synergism. Current study of herbal synergism including literature reported synergistic 
events, analysis methods in comparison with those of drug combination studies, clinical 
trial or in vivo test results, known commercial explorations, and the molecular 




5.1.1 Needs of evaluating synergistic mechanisms of herbal recipes 
 
There are conflicting views to the mechanism of reported therapeutic efficacies of 
herbs. One view argues that the reported efficacies of herbs can be due to placebo effects 
[Tausk 1998; Beyerstein 2001; Kaptchuk 2002; Lewith et al. 2002], and the other 
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attributes them to synergistic actions of the active ingredients in the corresponding herbs 
[Stermitz et al. 2000; Williamson 2001; Spinella 2002; Gilbert et al. 2003]. While their 
exact mechanism is still unclear, herbs have been widely explored as supplements and for 
therapeutic applications particularly in traditional medicines [Eisenberg et al. 1998]. 
Herb-based therapeutic approaches have been recognized as a valuable alternative to 
conventional medicine [Chan 1995a; Cheng 2000; Yuan et al. 2000a; Ang-Lee et al. 
2001b; Lazar 2004b]. Approximately 12% of the US population [Eisenberg et al. 1998] 
and 22%~23% of the preoperative and ambulatory patients [Kaye et al. 2000; Tsen et al. 
2000] have used herbal products in surveys conducted in the 1990s. For instance, positive 
outcomes have been obtained in rigorous clinical trials of a number of herbal extracts (e.g. 
Ginkgo biloba EGb761 [Mazza et al. 2006], St John's wort [Fava et al. 2005; Kasper et al. 
2006], north American ginseng [Predy et al. 2005], Isatis tinctoria [Heinemann et al. 
2004], and others [Kupfersztain et al. 2003; McKay et al. 2003; Kennedy et al. 2004; 
Kucera et al. 2004; Collene et al. 2005; Lopatkin et al. 2005; Tang et al. 2005; Winther 
et al. 2005; Huseini et al. 2006; Kemmerich et al. 2006], individual herbs [Bub et al. 200; 
Bradwejn et al. 2000; Simpson et al. 2001; Rein et al. 2004; Cheng et al. 2005; 
Jayawardena et al. 2005; Dowdy et al. 2006], and multi-herb recipes (e.g. Zemaphyte 
[Sheehan et al. 1992], PC-SPES [Oh et al. 2004] and others [Andersen et al. 2001; Hioki 
et al. 2004; Saxena et al. 2004; Chang et al. 2005; Hsu et al. 2005; Huseini et al. 2005; 
Kaiho et al. 2005; Morin et al. 2005; Naser et al. 2005; Park et al. 2005; Satoh et al. 2005; 
Suehiro et al. 2005; Ushiroyama et al. 2005; Wen et al. 2005; Zhong et al. 2005; Chan et 
al. 2006; Elder et al. 2006; Odaguchi et al. 2006; Wang et al. 2006; Wcw et al. 2006]. 
Because of their extensive applications, there is a need to scientifically evaluate the 
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therapeutic efficacy of herbs and multi-herb recipes and to determine their true 
mechanism of actions.  
 
Significant progress has been made in probing and analyzing bioactive ingredients 
of herbs [Sutter et al. 1993; Zhu et al. 1996; Li et al. 1998; Gong et al. 1999; Lee 1999]. 
In fact, approximately one third of the top-selling drugs currently in the market were 
derived from plant ingredients [Strohl 2000]. Natural products continue to be used as 
valuable sources for deriving new drug leads [Harvey 2000]. In spite of the wealth of 
information about their ingredients, the molecular mechanism and clinical pharmacology 
is known for only a small percentage of herbs [Sutter et al. 1993; Gong et al. 1999]. This 
hinders efforts for standardizing and scientifically evaluating herb-based therapeutics. A 
lack of the knowledge of mechanism also makes it difficult for more extensively 
exploring the therapeutic potential of some of the useful herbs and herbal recipes. 
Therefore more research is needed to fully understand the molecular physiological effects 
and therapeutic implications resulting from the interactions of herbal ingredients with 
human body and disease processes. 
 
It has been found that the contents of active ingredients in some herbs are lower 
than those needed to produce the expected therapeutic effects [Schmid et al. 2001; 
Williamson 2001; Danz et al. 2002], which has led to the skepticism about herbal 
medicines and the suggestions that therapeutic efficacies of herbs are due primarily to 
placebo effects[Tausk 1998; Beyerstein 2001; Kaptchuk 2002; Lewith et al. 2002]. On 
the other hand, there have been reports of the total contents of some herb showing a 
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significantly better effect than an equivalent dose of a single isolated active compound 
[Williamson 2001; Leonard et al. 2002; O'Byrne et al. 2002; Carpinella et al. 2003], and 
some herbal combinations being more effective than the constituent herb used alone 
[Scholey et al. 2002]. There are observations that in some cases alternative medicines are 
not necessarily associated with their positive or negative effects [Lewith et al. 2002]. 
These findings suggest that, while placebo effects may play important roles in some herb-
based therapies, it is possible for some of the herbs or herbal products to produce their 
therapeutic effects by synergistic, additive, or potentiative actions of their active 
ingredients [Stermitz et al. 2000; Williamson 2001; Spinella 2002; Gilbert et al. 2003]. 
Additive actions are also capable of enhancing therapeutic effects albeit at a less 
significant level per amounts of compounds than those of synergstic and potentiative 
actions. However, current work only focuses on the synergistic and potentiative actions to 
literature described synergistic effects of active herbal ingredients. 
 
5.1.2 Lessons from investigations of molecular mechanism of additive, synergistic, 
antagonistic, potentiative, and reductive effects of clinical drug-drug interactions 
 
Knowledge and tools generated from the extensive studies of additive, synergistic, 
antagonist, potentiative, and reductive effects are mostly from combinations of clinical 
drugs [Peters et al. 2000; Barrera et al. 2005; Jonker et al. 2005; Chou 2006; Tallarida 
2007]. The combinatorial effects of clinical drugs can be applied to investigate the effects 
and molecular mechanism of the interaction between herbal ingredients. 
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When two drugs produce similar effects, their combination collectively produces 
the same effect of various magnitudes in comparison to the summed response of the 
individual drugs. A combination is pharmacodynamically additive, synergistic, or 
antagonistic if the effect is equal to, greater than, or less than the summed response of the 
participating drugs. Drug combinations may also produce pharmacokinetically 
potentiative or reductive effects such that the therapeutic activity of one drug is enhanced 
or reduced by the action of the other drug via regulation of its metabolism, transport, 
permeation, distribution or localization [Chou 2006]. Synergism of drug combinations 
have been explored for therapeutic applications to achieve one or more of the following 
favorable outcomes: enhanced therapeutic efficacies, decreased dosage with the same or 
increased level of efficacy for reducing side-effects, reduced or delayed development of 
drug resistance, simultaneous enhancement of actions against a target and reduction of 
unwanted actions (efficacy synergism plus toxicity antagonism) [Chou 2006].  
 
Synergism is hence expected to occur if two or more herbal ingredients mutually 
enhance each other’s therapeutic effects more significantly than simple sum of these 
ingredients [Phillipson 1999; Williamson 2001; Spinella 2002; Gilbert et al. 2003]. 
Signficant enhancement effects may occur via pharmacokinetic actions such as the 
modulation of bioavailability of active ingredients by others [Stermitz et al. 2000; 
Spinella 2002]. In fact, combination of different herbs may eliminate problematic side 
effects associated with some of the ingredients [Morre et al. 2003b; Shao et al. 2004]. 
These might be the main reasons why many of the proclaimed effective herbal products 
have been provided as sets of multi-component herbal extracts or multiple herbs, and why 
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the reported therapeutic efficacy of these herbal products [Williamson 2001; Spinella 
2002; Gilbert et al. 2003] and traditional medicines [Cheng 2000; Yuan et al. 2000a] are 
believed to arise from collective effects of herbal ingredients. Although synergistic 
effects are considered to be positive and beneficial in general, there are also instances that 
show negative and adverse reactions that tend to be more apparent with combinations of 
herbs than with prescribed synthetic medicines [Williamson 2001]. Therefore, 
comprehensive studies at the molecular level and clinical analyses are needed to 
conclusively demonstrate the existence of herbal synergism and their real contribution to 
the therapeutic and toxicological effects of herbal products.  
 
5.2 Methods 
5.2.1 Literature search method for cases of drug-drug interactions 
 
A number of computational analysis methods have been developed and extensively 
used for accurately studying the effect of drug combinations, which are particularly 
useful for differentiating synergistic and additive effects. Examples of the popular 
methods are checkerboard method, combination index, fractional effect analysis, 
isobolographic analysis, interaction index method, median drug effect analysis, and 
response surface approach [Peters et al. 2000; Barrera et al. 2005; Jonker et al. 2005; 
Chou 2006; Tallarida 2007]. Other methods such as Valeriote & Lin’s comparative 
analysis method [Primeau et al. 2003], Yonetani & Theorell plot [Cruchaga et al. 2005] 
and 3D model of drug-drug interactions[Prichard et al. 1990] have also been used for 
studying drug combinations. 
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Insights into how drug combinations contribute to their additive, synergistic, 
antagonistic, potentiative, or reductive activities can be obtained from analysis of 
reported cases of known mechanisms of actions as well as assessments of combinatorial 
effects by established drug effect analysis methods. Relevant literatures were searched in 
Medline [Wheeler et al. 2004] by using combinations of keywords such as “drug 
combination”, “drug-drug interaction”, “additive”, “synergism”, “synergy”, “synergistic”, 
“antagonism”, “antagonistic”, “potentiation”, “potentiate”, “potentiative”, “reductive”, 
“reduction”, and “reductive” to identify 12, 35, and 8 cases of pharmacodynamically 
additive, synergistic, and antagonistic drug combinations and 18 and 7 cases of 
pharmcokinetically potentiative and reductive drug combinations published in 2000-2006 
where the molecular mechanism of combination effects have been determined by 
established synergism/additive/antagonism analysis.  
 
 
5.2.2 Literature search method for cases of herbal synergism 
 
Combinations of keywords of “herb”, “herbs’, “herbal”, “plant”, or “plants’ 
together with those of “synergy”, “synergistic”, and “synergism” were used to search the 
Medline database [Wheeler et al. 2004] to find literature reported cases of synergism of 
herbs and herbal products, which were subsequently checked for the availability of the 
information about the active ingredients of the herbs involved. The information of these 
active ingredients were searched from authoritative books of medicinal herbs [Xinquan et 
al. 2002] and Medline database [Wheeler et al. 2004] by using combinations of herb 
names and the keywords “ingredient”, “constituent”, or “component”. Some of the 
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identified herbs or herbal extracts, and thus their reported synergistic effect, have been 
explored in commercial products. The relevant information was searched by using the 
combinations of herb names and the keywords “commercial”, “product”, or “company” 




5.3.1 Pharmacodynamically additive, synergistic, and antagonistic combinations of 
clinical drugs 
 
The reported cases of these pharmacodynamic and pharmacokinetic drug 
combinations are summarized in Table 5.1 and Table 5.2, respectively. As shown in 
Table 5.1 there are 5, 5, 1 and 1 of the 12 cases of pharmacodynamically additive drug 
combinations involve drug actions at the same target, different targets of related 
pathways, different targets of the same pathway, and different targets of unrelated 
pathways, respectively. Many of these additive drug combinations are associated with 
overlapping drug actions at the same target that might produce mutually substitutable or 
redundant effects. For instance, combination of doxorubicin and Ecteinascidin-743 
produces additive anticancer effect via redundant action of DNA intercalation and 
covalent guanine adduct formation at specific sites in DNA minor groove [Meco et al. 
2003].  
 
In 3 out of 5 cases of additive drug combinations acting on different targets of 
same pathway, additive effects appear to occur when the corresponding actions are 
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significantly overlapping such that they produce focused actions on the activity and 
expression level of a specific target and its closely associated molecules. For instance, 
retinoic acid and trichostatin A additively inhibit cell proliferation by overlapping actions 
in up-regulating retinoic acid receptor beta and reactivation of its messenger RNA 
(mRNA) expression [Touma et al. 2005]. There are 2 cases of additive drug 
combinations acting on different targets of different pathways, in which the 
corresponding actions appear to be independent of each other. For instance, CP55940 
(cannabinoid analog) and morphine produce additive antinociceptive effects in some 
cases via independent actions of cannabinoid antagonism and mu opioid receptor 
agonism [Tham et al. 2005].  
 
There are 12, 15, and 5 of the 32 cases of synergistic drug combinations that 
involve drug actions at different targets of the same pathway, different targets of related 
pathways, and different binding sites or different sections of the same site of the same 
target, respectively. Non-competitive inhibitors, antagonists, and blockers are potential 
candidates for finding synergistic combinations that interact with the same target. 
Synergistic drug combinations in these 32 cases appear to primarily arise from 
complementary (19 cases), facilitating (4 cases), negative effect reducing (3 cases), 
derivative which derives new effect (1 case), and partially overlapping (5 case) actions. 
The remaining 4 cases involve overlapping or independent actions and it is unclear how 
these combinations lead to synergism. One possible reason for these cases is that 
additional interactions contributing to the observed synergism have not been exposed. An 
example of complementary actions against different targets of the same pathway is 
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cisplatin-topotecan combination for producing synergistic cytotoxic activity [van 
Waardenburg et al. 2004]. Cisplatin forms inter- and intra-DNA strand adducts that 
inhibites DNA polymerization. On the other hand, topotecan targets DNA polymerase I 
by reversibly stabilizing covalent enzyme-DNA intermediate, which stops mutagenic 
translesional bypass replication across cisplatin-DNA adducts and subsequently produces 
complementary effects [Lin et al. 1999; Rhee et al. 2002].  
 
An example of negative effect reducing combinations is tamoxifen-trastuzumat 
combination that synergistically inhibits the growth of estrogen receptor positive, HER-
2/neu-overexpressing BT-474 breast tumor cells [Argiris et al. 2004]. Tamoxifen is an 
estrogen receptor antagonist and rastuzumab is an anti-HER-2/neu antibody that interacts 
with different targets of related pathways. Trastuzumab stops HER-2/neu induced 
activation of estrogen receptor and coactivator AIB1 (amplified in breast cancer-1), while 
tamoxifen stops estrogen receptor induced activation of growth factor pathways, thereby 
reducing the negative effects of each other [Osborne et al. 2003].  
 
There are 5 and 2 of the 7 cases of antagonistic drug combinations that involve 
drug actions at the same target and different targets of related pathways, respectively. 
While the exact mechanism of antagonism has not been explicitly described for the cases 
involving drug actions at the same target, one possible mechanism is mutual interference 
at the same target site, which can be illustrated by the carboplatin- paclitaxel combination 
[Guminski et al. 2001]. Carboplatin is a cisplatin anolog that forms covalent adduct with 
DNA and alters its local conformation. Paclitaxel is an external DNA binder that partially 
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stabilizes DNA helix without altering its B-conformation. Such a binding conformation is 
incompatible with that of carboplatin, which may be an important factor for the 
antagonism.  
 
Combination of other mutually interfering pairs of twin competitive inhibitors, 
antagonists, blockers, activators, or agonists may produce pharmacodynamically 
antagonistic effects. Likewise, inhibitor-activator, antagonist-agonist, or blocker-substrate 
pairs that bind to the same site may also produce mutually antagonistic effect. A possible 
mechanism for antagonistic drug combinations against different targets of related 
pathways is the counteractive actions that make it unfavorable for a partner drug to 
perform its normal actions, which can be illustrated by the Ara-C and 17-AAG 
combination [Pelicano et al. 2006]. Ara-C is a DNA binder, and 17-AAG is a heat-shock 
protein antagonist that abrogates Akt survival pathway. 17-AAG antagonizes the 
cytotoxic activity of ara-C, due in part to the induction of G1 arrest, thereby preventing 
ara-C incorporation into cellular DNA. 
 
5.3.2 Pharmacokinetically potentiative and reductive combinations  
 
As shown in Table 5.2 there are 9, 8 and 5 of the 22 cases of potentiative drug 
combinations that involve modulation of drug transport/permeation, 
distribution/localization, and metabolism, respectively. The primary mechanisms of 
potentiative modulations of drug transport/permeation are enhancement of drug 
absorption via disruption of transport barrier, delay of barrier recovery, or reduction of 
first-pass excretion via inhibition of drug efflux. The main mode of actions of 
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potentiative modulation of drug distribution/localization is to increase drug concentration 
in plasma or specific tissue by blocking drug uptake and inhibiting metabolic processes 
that convert drugs into excretable forms. Potentiative metabolism modulation is primarily 
associated with stimuation of the metabolism of drugs into active forms, and inhibition 
the metabolism of drugs into inactive forms. Typical potentiative effects can be 
illustrated by the example of cyclosporine enhancement of the actions of rosuvastatin 
[Simonson et al. 2004]. Rosuvastatin decreases levels of atherogenic lipoproteins in 
patients with or at high risk of cardiovascular disease via HMG-CoA (3-hydroxy-3-
methyl-glutaryl-CoA) inhibition. As a substrate of OATP-C (organic anion transporting 
polypeptide-C), systemic exposure of rosuvastatin is decreased by OATP-C mediated 
uptake process. Inhibition of this process by cyclosporine therefore enables an increase of 
rosuvastatin concentration.  
 
There are 2, 2 and 3 of the 7 cases of reductive drug combinations that involve 
modulation of drug transport/permeation, distribution/localization and metabolism, 
respectively. Reductive modulation of drug transport/permeation typically involves the 
blocking drug absorption or promotion of first-pass excretion by such actions as drug-
drug aggregation to reduce permeability and inhibition of drug transport into plasma or 
target site. Reductive modulation of drug distribution/localization is associated with the 
decrease of drug concentration in plasma or specific tissue, which typically involves 
stimuation of metabolic processes for converting drugs into excretable forms and 
inhibition of metabolic processes for increasing drug concentation. In addition, drug 
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activity can also be reduced by metabolism modulation to covert drugs into inactive 
forms. 
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Table 5.1 Literature reported pharmacodynamically additive, synergistic, and antagonistic drug combinations in 2000-2006, where reported action 







Mode of actions Drug combinations reported to have the effect 
arising from this mode of actions [reference] 
Example of drug-combination and reported 




Ampicillin-Imipenem[Rand et al. 2004];   
Diazoxide-Sodium nitroprusside[Alves et al. 2004];  
Diazoxide-Dibutyryl-cGMP[Alves et al. 2004];  
Propofol –Sevoflurane[Harris et al. 2006]; 
Ampicillin blocked penicillin-binding protein 2A 
and thus bacterial cell wall synthesis. Imipenem 
inhibited penicillin-binding protein -1A, -1B, -2, -4 
and -5. These produce mutually substitutable actions 
on penicillin-binding protein 2A, producing additive 
antibacterial effect[Rand et al. 2004] 
Same target 
Overlapping 
actions on different 
binding sites 
Doxorubicin-ET-743[Meco et al. 2003]; Doxorubicin intercalated DNA. ET-743 formed 
covalent guanine adduct at specific sites in DNA 
minor grove and interacted with DNA repair system, 







actions on targets 
of the same 
pathway 
Retinoic acid -Trichostatin A[Touma et al. 2005]; Retinoic acid up-regulated retinoic acid receptor 
beta. Trichostatin A, a histone deacetylase inhibitor, 
reactivated retinoic acid receptor beta mRNA 
expression. They produce overlapping action by 
interacting with the up- and down- stream targets of 
the same pathway, resulting in additive inhibition of 
cell prolifer ation[Touma et al. 2005] 
Independent 
actions on targets 
of related 
pathways 
Anidulafungin- Amphotericin B [Karlowsky et al. 2006]; 
Artemisinin-Curcumin[Nandakumar et al. 2006]; 
CP55940-Dexmedetomidine[Tham et al. 2005]; CP55940-
Morphine[Tham et al. 2005];  
Anidulafungin inhibited beta-(1,3)-dglucan 
synthase, an essential component of fungal cell wall. 
Amphotericin B formed ion channels in fungal 
membranes. They independently targeted different 
targets of related pathways, producing additive 








actions on targets 
of related 
pathways 
Azithromycin-Imipenem[Fernandez-Cuenca et al. 2003];  Azithromycin hindered bacterial protein synthesis 
by binding to 50S component of 70S ribosomal 
subunit. Imipenem inhibited penicillin-binding 
protein -1A, -1B, -2, -4 and -5. The former reduces 
penicillin-binding proteins to complement the later’s 
inhibition of these proteins, producing additive 
antibacterial effect[Fernandez-Cuenca et al. 2003] 






actions on targets 
of un-related 
pathways 
Citicoline-Nimodipine[Sobrado et al. 2003];  Citicoline increased BCL-2 expression. Nimodipine 
blocked L-type voltage sensitive calcium channel. 
They act independently on targets of un-related 
pathways, producing additive neuroprotective 
effect[Sobrado et al. 2003] 
negative effect 
reducing actions 
AZT- NNRTI[Cruchaga et al. 2005]; AZT is a HIV-1 reverse transcriptase inhibitor,  
NNRTI (Non-nucleoside HIV-1 reverse 
transcriptase inhibitor) inhibited RT catalyzed 
phosphorolysis, thereby reduced AZT resistance, 






Cisplatin-Yondelis[D'Incalci et al. 2003];  Mycophenolate 
mofetil – Mizoribine[Shimmura et al. 2006];  Paclitaxel-
Discodermolide[Honore et al. 2004]; Paclitaxel-
Ecteinascidin 743 [Takahashi et al. 2002];  
Cisplatin formed DNA inter- and intra- strand 
adduct, Yondelis interacted with DNA and DNA 
repair systems in a way different from cisplatin, 




Gefitinib - CPT-11[Koizumi et al. 2004];  Gefitinib inhibited EGFR tyrosine kinase inhibitor. 
CPT-11, a DNA topoisomerase I inhibitor, increased 
EGFR phosphorylation in Lovo & WiDR cells. 
EFFR tyrosine kinase inhibitor offsets negative 
effect of increased EGFR phosphorylation by CPT-
11, producing synergistic inhibitory effect on 




5-AZA-2’-deoxycytidine – Depsipeptide[Primeau et al. 
2003];  
Candestartan-cilexetil –Ramipril[Raasch et al. 2004];  
Celecoxib – Emodin[Lai et al. 2003]; Cisplatin-
Topotecan[Lin et al. 1999; Rhee et al. 2002; van 
Waardenburg et al. 2004];  
Gefitinib - PD98-59[Normanno et al. 2006];  Oxaliplatin - 
CPT-11[Tanaka et al. 2005];  
Paclitaxel-Lonafarnib[Shi et al. 2000]; Paclitaxel-
SCH66336 [Marcus et al. 2005]; 
Paclitaxel –Tubacin[Marcus et al. 2005];  Paclitaxel –
Trichostatin[Dowdy et al. 2006];  
5-AZA-2’-deoxycytidine inhibited DNA 
methyltransferase -1 and -3B. Depsipeptide, a 
histone deacetylase inhibitor, induced tumor 
suppressor genes. The former stops silencing of 
tumor suppressor genes in cancer cells to 
complement the later’s induction of tumor 
suppressor genes, producing synergistic 





targets of  




17-AAG - Arsenic trioxide[Pelicano et al. 2006];  17-AAG, a heat-shock protein antagonist, abrogated 
Akt survival pathway. Arsenic trioxide degraded 
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actions aberrant PML-retinoic acid receptor alpha fusion 
protein and affected intracellular signal transduction 
pathways. They possiblly produce partially 
overlapping actions on Akt survival pathway, 
resulting in synergistic effect on long-term cell 
survival[Pelicano et al. 2006] 
Complementary 
actions 
5-FU - RPR-115135 [Russo et al. 2002]; Azithromycin-
Ceftazidime[Fernandez-Cuenca et al. 2003]; 
Dexmedetomidine-ST-91[Graham et al. 2000; Philipp et 
al. 2002]; Dipropofol-Vancomycin[Ogata et al. 2005]; 
DL-cycloserine-Epigallocatechin gallate[Zhao et al. 
2001]; Gefitinib-Taxane[Takabatake et al. 2007]; 
R115777 - Zoledronic acid[Caraglia et al. 2004];  
Paclitaxel -NU6140[Pennati et al. 2005]; Bacterial protein 
inhibitor-Antisense drug targeting mRNA of bacterial 
protein[Dryselius et al. 2005]; 
5-FU stabilized P53 due to RNA-directed effects. 
RPR-115135, a farnesyl transferase inhibitor, 
inhibited Ras farnesylation. These produce joint 
tumor suppressive and antiproliferative activities, 




Tamoxifen-Trastuzumab[Osborne et al. 2003; Argiris et 
al. 2004]; 
Tamoxifen antagonized estrogen receptor. 
Trastuzumab (herceptin) is an anti-HER-2/neu 
antibody. Trastuzumab stops HER-2/neu induced 
activation of estrogen receptor and coactivator 
AIB1, tamoxifen stops estrogen receptor induced 
activation of growth factor pathways, leading to 
synergistic growth inhibition in ER- positive, HER-
2/neu -overexpressing BT-474 breast tumor 
cells[Osborne et al. 2003; Argiris et al. 2004] 
facilitating actions Ampicillin-Daptomycin[Rand et al. 2004]; CP55940-
Dexmedetomidine; Daptomycin-Rifampicin[Rand et al. 
2004]; Gentamicin-Vancomycin[Cottagnoud et al. 2003];  
Ampicillin blocked penicillin-binding protein 2A 
and thus bacterial cell wall synthesis. Daptomycin 
disrupted bacterial membrane structure, which 
enhances ampicillin penetration, producing 





Extra actions BQ-123-Enalapril[Goddard et al. 2004]; BQ-123 antagonized endothelin A receptor. 
Enalapril, an angiotensin converting enzyme 
inhibitor, increased ETB mRNA expression. BQ-
123 displaces endogenous ET-1 from the ETA onto 
upregulated ETB, which produces an extra ETB 
mediated vasodilation activity, resulting in 
synergistic endothelium-dependent vasodilation 
enhancing actions[Goddard et al. 2004] 
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Same target Possible mutual 
interference 
Aminophylline-Theophylline[Nickels et al. 2006]; 
Chloroquine-Mefloquine[Famin et al. 2002]; Chloroquine-
Pyronaridine[Auparakkitanon et al. 2006]; Tramadol-
Ondansetron[Riering et al. 2004; Dursteler et al. 2006]; 
Carboplatin-Paclitaxel[Guminski et al. 2001];  
Aminophylline and Theophylline both antagonized 
adenosine receptor. Their combination produced 
antagonism of inhibitory adenosine autoreceptors 










17-AAG - Ara-C[Pelicano et al. 2006];  
Amphotericin B-Ravuconazole[Carrillo-Munoz et al. 
2006; Meletiadis et al. 2006]; 
17-AAG, a heat-shock protein antagonist, abrogated 
Akt survival pathway. Ara-C is a DNA binder. 17-
AAG antagonized the cytotoxic activity of ara-C, 
due in part to induction of G1 arrest, thus preventing 
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Table 5.2 Literature reported pharmacokinetically potentiative and reductive drug combinations in 2000-2006, where the reported effect has been 







Mode of actions Drug combinations reported to 
have the effect arising from this 
mode of actions [reference] 






AZT – Cineole[Narishetty et al. 
2004]; 
Low molecular weight heparin – 
Chitosan[Thanou et al. 2001]; 
Low molecular weight heparin - 
Sodium caprate[Tomita et al. 1995; 
Verhaeghe 1998; Motlekar et al. 
2005] 
AZT is a HIV-1 reverse transcriptase inhibitor. Cineole formed 
hydrogen bonds with lipid head groups of stratum corneum lipids. 




avoiding its efflux 
Doxorubicin - HPMA 
copolymer[Duncan et al. 2005]; 
Doxorubicin produced anticancer effect by DNA intercalation. 
HPMA copolymer formed conjugate with anthracycline, which 
enabled bypass of multi-drug resistance[Duncan et al. 2005] 
Avoided drug 
excretion 
Ciprofloxacin – Gatifloxacin[Pankey 
et al. 2005]; 
Fexofenadine-Probenecid[Nakajima 
et al. 2004]; 
Ciprofloxacin inhibited DNA gyrase, an enzyme specific and 
essential for all bacteria. Gatifloxacin inhibited efflux pump of 
ciprofloxacin, producing synergistic antibacterial action against 
pseudomonas aeruginosa via efflux pump inhibition[Pankey et al. 
2005] 
Drug transport and 
permeation 
Delayed recovering 
of drug transport 
barrier 
Levodopa - Fatty acid synthesis 
inhibitor[Tsai et al. 1996; Koller et 
al. 1998; Babita et al. 2005]; 
Levodopa is a dopaminergic agent for treating Parkinson's disease. 
Fatty acid synthesis inhibitor selectively inhibited fatty acid 
synthesis, which delayed barrier recovery rates after barrier 
perturbation of drugs, thereby enhanced transcutaneous delivery of 





Enhanced level of 





Gemfibrozil[Prueksaritanont et al. 
2002; Fujino et al. 2003; Shitara et al. 
2004]; 
5-FU – Sorivudine[Kanamitsu et al. 
2000]; 
Rosuvastatin-Cyclosporine[Simonson 
et al. 2004];  
Rosuvastatin-Gemfibrozil[Schneck et 
al. 2004];  
Cerivastatin produces cholesterol-lowering effect by inhibiting 
HMG-CoA reductase. Gemfibrozil inhibited OATP2 mediated 
uptake of cerivastatin and CYP2C8 mediated metabolism of 
statins, thereby increased plasma concentration of cerivastin and 
other statins [Prueksaritanont et al. 2002; Fujino et al. 2003; 
Shitara et al. 2004] 
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Enhanced level of 
prodrug metabolite 
HSV thymidine kinase gene and 
ganciclovir – Scopadulcio[Hayashi et 
al. 2006]; 
HSV thymidine kinase gene and 
ganciclovir – Ponicidin[Hayashi et al. 
2000]; 
Ganciclovir in combination of HSV thymidine kinase gene therapy 
has been used for anticancer treatment. Scopadulcio stimulated 
HSV thymidine kinase activity, increased levels of ganciclovir 
metabolite. Improved efficacy of cancer gene therapy via enhanced 
activity and increased level of prodrug metabolite[Hayashi et al. 
2006] 
Drug metabolism Enhanced 
metabolism of 
prodrug into active 
metabolite 
5-FU - 2'-deoxyinosine[Ciccolini et 
al. 2000]; 
Doxorubicin-Paclitaxel[Minotti et al. 
2001]; 
 
5-FU is metabolized by thymidine phosphorylase and others, 
metabolite stabilized P53 due to RNA-directed effects, producing 
anticancer effect. 2'-deoxyinosine is a modulator that enhances 
thymidine phosphorylase activity, thereby enhanced antitumor 
activity of 5-fluorouracil in human colorectal cell lines and colon 




Amphotericin B – Miltefosine[Menez 
et al. 2006]; 
Amphotericin B, an antileishmanial, formed aggregate with 
Miltefosine, an antileishmanial, thereby reduced miltefosine-
induced paracellular permeability enhancement in Caco-2 cell 
monolayers, inhibited uptake of both drugs, decreased 
transepithelial transport of both drugs[Menez et al. 2006] 





Luteolin[Wang et al. 2007]; 
Gamma-hydroxybutyrate, a drug of abuse, increased dopamine 
concentration, its disposition and renal reabsorption is mediated by 
MCT1 transporter. Luteolin exhibited MCT1 transporter mediated 
uptake of gamma-hydroxybutyrate, which significantly increased 
renal and total clearances of gamma-hydroxybutyrate[Wang et al. 
2007] 
Reduced level of 
drug in plasma by 
metabolism 
inhibition 
Valproic acid – Carbapenem[Perucca 
2002; Nakajima et al. 2004]; 
Valproic acid, an antiepileptic, is metabolized into valproic acid 
glucuronide. Carbapenem antibiotics inhibited the hydrolytic 
enzyme involved in the hydrolysis of valproic acid glucuronide to 
valproic acid, resulting in a decrease of plasma concentration of 
valproic acid, which caused seizures in epileptic patients due to 




Reduced level of 
drug by complex 
formation 
Cisplatin - Procainamide 
hydrochloride[Zicca et al. 2002]; 
Cisplatin is a DNA inter- and intra- strand adduct. Procainamide 
hydrochloride formed cisplatin-procainamide complex, thereby 
reduced cisplatin-induced hepatotoxicity via formation of less 
toxic platinum complex, leading to inactivation of cisplatin or its 
highly toxic metabolites and to a different subcellular distribution 
of platinum[Zicca et al. 2002] 
pharmacokinetically 
reductive 
Drug metabolism Enhanced 
metabolism of 
Warfarin-Quinidine[Ngui et al. 
2001]; 
Warfarin, an anticoagulant and antithrombotic, is metabolized by 
CYP3A4. Quinidine stimulated CYP3A4 mediated metabolism of 
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active drug into 
inactive metabolite 
Diclofenac-Quinidine[Ngui et al. 
2000]; 
Mycophenolate mofetil – 
Rifampin[Kuypers et al. 2005]; 
warfarin, thereby reduced anticoagulanet effect of warfarin by 
stimulating its metabolism[Ngui et al. 2001] 
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5.3.3 Literature described cases of herbal synergism 
 
In many cases, literature reported synergism is not specific enough to point to the 
clues about their possible molecular mechanism. Typical words or sentences of synergy 
descriptions in these reports are antioxidant synergism [Hwang et al. 2001], anti-HIV 
synergy [Mahmood et al.], synergy in spasm and pain relief [Huang et al.], antioxidant 
synergy between elements in leaf [Saada et al.], synergistically induced leukemia cell 
HL60 differentiation [Ariga et al.], antimicrobial action of berberine potentiated by 5'-
methoxyhydnocarpin [Stermitz et al. 2000], camphor and 1,8-cineole produced 
antibacterial synergism [Viljoen et al. 2003], synergistic antibacterial effect of 
monomeric polyphenols epigallocatechin gallate (EGCG) and (-)-gallocatechin gallate 
(GCG) in the extract of oolong tea [Sasaki et al. 2004], and isoflavones extracts 
potentiate the antibacterial activity of alpha-linolenic acid [Morel et al. 2003]. 
 
In some reports, useful clues about the possible molecular mechanism of 
synergism are provided. For instance, it has been reported that revestratrol and catechin 
produced synergistic protection of PC12 cells from beta-AP toxicity of hydrogen 
peroxide [Conte et al. 2003b]. In another report, the Ginkgo biloba extract (EGb 761) and 
bilobalide have been found to provide synergistic protection against ischemia-induced 
neuronal death in vivo and glutamate-induced neuronal death in vitro involving anti-
excitotoxicity, inhibition of free radical generation, scavenging of reactive oxygen 
species, and regulation of mitochondrial gene expression [Chandrasekaran et al. 2002]. 
There is also a report about phytoestrogen and ascorbic acid synergistically inhibiting low 
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density lipoprotein (LDL) oxidation [Hwang et al. 2000]. Moreover, Pd-Ia, pteryxin and 
Pra-C have been found to produce synergistic calcium antagonistic action for relaxing the 
smooth muscle of tracheas and pulmonary arteries [Zhao et al. 1999]. Other examples of 
the synergy descriptions are synergistic inhibition of low-density lipoprotein oxidation by 
rutin and gamma-terpinene [Milde et al. 2004], and the combined inhibition of estrogen-
dependent human breast carcinoma by soy and tea bioactive components [Zhou et al. 
2004]. 
5.3.4 Assessment of herbal synergism determination methods 
 
The synergism determination methods used in the 19 cases of literature reported 
pharmacodynamic synergisms, which are given in Table 5.3 and Table 5.4, can be 
divided into 3 groups. The first group includes 4 cases where synergism has been 
determined by an established drug combination analysis method such as isobolographic 
analysis [Mahmood et al. 1996], interaction index [Savelev et al. 2003], and ANOVA 
(Analysis of Variance) tools [Hsieh et al. 1999; Hostanska et al. 2003]. The second group 
consists of 4 cases where synergism has been determined by direct comparison of 
effective concentrations. Synergism is assumed to exist if the effective concentration of 
ingredients in combination is significantly reduced with respect to that of individual 
ingredient. A large enough margin of effective concentration reduction is usually needed 
to confidently distinguish synergism and additive effect. Two of the 4 cases appear to 
have large enough margin. In one case, the principal ingredients of tea extracts (-)-
epicatechin, (-)-epigallocatechin-3-gallate, (-)-epicatechin-3-gallate, and theaflavins in 
combination are effective against AH109A cell proliferation at concentrations 10-fold 
smaler than in that of individual ingredient in separation [Zhang et al.]. In the second 
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case, resveratrol and catechin in combination protect PC12 cells from beta-AP (1-41) 
toxicity of hydrogen peroxide at concentrations 2~5 times smaler than that of individual 
ingredient in separation [Conte et al. 2003b]. The synergism detection results of the 
remaining 2 cases are difficult to judge. 
 
The third group contains 11 cases where synergism has been determined by direct 
comparison of effects. Synergism is assumed to exist if the effect of ingredients in 
combination is significantly increased with respect to that of individual ingredient. 
Reliability of this approach depends on whether the effects of ingredients in combination 
are truly greater than individual alone combined. Based on the results described by the 
respective publications, 8 of these 11 cases appear to satisfy this criterion. For instance, 
capsicum-tea mixtures, which contain active ingredients (-)-epigallocatechin-3-ga llate, 
catechin, caffeine, and vanilloid capsaicin, have been found to produce 10-fold stronger 
anticancer activity than that of individual ingredient [Morre et al. 2003a]. Therefore the 
effect of these ingredients in combination is clearly greater than individual alone 
combined. In another example, the low-density lipoprotein oxidation inhibition activity of 
rutin and gamma-terpinen combination has been found to be better than the computed 
value of individual alone combined [Milde et al. 2004]. The synergism detection results 
of the remaining 3 cases are difficult to judge. 
 
Overall, 74% of the 19 cases of reported synergism appear to give reliable 
prediction eventhough only a few of them are based on the established analysis methods 
on drug combination. None-the-less, the use of established drug combination analysis 
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methods is recommended because of their higher level of accuracy, efficiency, and 
conveniency in facilitating the determination of synergistic effects, particularly in 
distinguishing synergistic and additive effects. 
 
5.3.5 Modes of putative molecular interactions contribute to synergism of herbal 
ingredients 
Based on literature reported molecular analysis of additive, synergistic, 
antagonistic, potentiative, and reductive actions of drug combinations, it appears that the 
same molecular mechanisms play important roles in the postulated or proclaimed herbal 
synergism. For active ingredients that produce similar therapeutic actions, their 
combinations may lead to synergistic effects when they interact with different targets of 
the same pathway, or different targets of related pathways, different binding sites of the 
same target, or different section of the same site of the same target in such a way that 
their actions are complementary, or facilitating, or negative effect reducing, or derivative, 
or partially overlapping. Non-competivite inhibitors, antagonists, and blockers are 
potential candidates for finding synergistic combinations of ingredients interacting with 
the same target.  
 
For active ingredients that produce different actions, e.g. one therapeutic and 
another non-therapeutic or irrelevant, the therapeutic effects of one ingerident may be 
potentiated by the second ingredient to produce a pharmacokinetically potentiative effect 
when the second ingredient modulates the transport/permeation, distribution/localization, 
or metabolism of the first ingredient in such a way that it disrupts transport barrier, delays 
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barrier recovery, inhibits efflux of the first ingredient, blocks uptake of the first 
ingredient, inhibits metabolic processes for converting the first ingredient into excretable 
form, stimulates the metabolism of the first ingredient into active form, or inhibits the 
metabolism of the first ingredient into inactive form. 
 
While at a less significant level per amounts of compounds than those of 
synergistic combinations, combinations of active ingredients of similar therapeutic 
actions producing additive effects also lead to enhanced therapeutic effects of herbs and 
herbal products. Therefore, additive combinations may also need to be evaluated in 
studying the molecular mechanism of collective enhancement effects of herbal 
ingredients. For active ingredients that produce similar therapeutic actions, their 
combinations may lead to additive effects when they interact with completely 
independent targets, or the same target in such a way that their actions are mutually 
substitutable or redundant, or different targets of related pathways in such a way that their 
actions are focused on the activity and expression level of a specific target and closely 
associated molecules.    
5.3.6 Literature reported molecular interaction profiles of herbal active ingredients 
 
As part of the effort for studying the molecular mechanism of herbs and for 
screening new therapeutic drug leads from plant sources, a large number of biologically 
active ingredients have been extracted from herbs and other natural sources and many of 
these have been studied for their potential therapeutic effects [Sutter et al. 1993; Zhu et al. 
1996; Li et al. 1998; Gong et al. 1999; Lee 1999].  The DNP (Dictionary of Natural 
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Products) module of the chemical database CCD [Chapman&Hall/CRC 2005] contains 
40,000 chemicals extracted from plant sources. A traditional Chinese medicine database 
TCM-ID [Wang et al. 2005d] has a collection of 9852 ingredients isolated from herbs 
used in traditional Chinese medicine. These databases are therefore excellent sources for 
obtaining information about active herbal ingredients. Not all ingredients of an herb 
found from sources such as CCD [Chapman&Hall/CRC 2005] and TCM-ID [Wang et al. 
2005d] databases are active ingredients. Additional literature study was conducted to 
select the active ingredients from the pool of all ingredients by the condition that they 
either have been explicitly reported to be an active constituent, or are of higher 
abundances in their host herb, or they have been reported to produce an effect consistent 
with a literature-described effect of their host herb.  
 
The molecular interaction profile of an active ingredient describes its interaction 
with a specific biomolecule, or its interference with a biological pathway or biological 
process. These literature-reported profiles can be retrieved from the Medline database 
[Wheeler et al. 2004] by keyword search using the name or alternative names of an 
ingredient combined with the name or alternative names of each of the known proteins, 
pathways, and biological processes. Overall, at least one literature-described molecular 
interaction profile for ~50% of the ingredients can be found. The number of literature-
described interacting partners of an active ingredient varies significantly, with some 
ingredient having more than a few dozen interacting partners. The significant variation in 
the number of the literature-described interaction partners likely arises partly from the 
intrinsic differences in the binding specificity of these ingredients and partly because of 
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the differences in the extent of research effort directed at these ingredients. However, 
statistically meaningful clues may still be obtained from these literature-described 
molecular interaction profiles. 
 
A majority, about 40%, of our collected literature-described molecular interaction 
profiles of active herbal ingredients directly point to a specific biomolecule as the 
interaction partner and provide the information about the type of interaction in terms of 
inhibition, activation, and expression patterns. Typical examples of the relevant 
descriptions are genistein inhibited metmyoglobin-dependent LDL oxidation [Patel et al. 
2001], daidzein increased catalase level by activating its promoter[Rohrdanz et al.], 
catechin gallate inhibited P-glycoprotein [Jodoin et al. 2002], resveratrol inhibited 
cytochrome P450 CYP1A2 [Chang et al.; Ursing et al.], and 2-Phenylethanol-O-(6-O-
galloyl)-beta-D-glucopyranoside 8 interacted with viral protein gp120 and prevented its 
binding to CD4 (cluster of differentiation 4) [Mahmood et al.]. Hence, it is possible to 
determine both the pharmacodynamic synergism and pharmacokinetic potentiative effects 
of these herbal ingredients based on the expected effects of these interactions on the 
therapeutic, toxicological, or pharmacokinetic actions of some of these ingredients.  
 
Although the relevant molecular target is not exactly specified, some of the 
literature-described molecular interaction profiles identify specific pathway or process as 
the interaction partner of an herbal ingredient and point out the pharmacodynamic or 
pharmacokinetic consequence of this interaction. For instance, (-)-epigallocatechin-3-
gallate has been described to potently inhibit the tumor cellular proteasome activity, 
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which may contribute to the cancer-preventative effect of green tea [Kuhn et al.]. 
Caffeine is known to exert its antioxidant effect by quenching reactive species 
[Devasagayam et al. 1996] as well as by increasing the activity of superoxide dismutase 
[Rossowska et al. 1995]. Apparently, this kind of information is useful for finding the 
clues to both the pharmacodynamic and pharmacokinetic effects of these herbal 
ingredients 
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Table 5.3 List of medicinal herbs or herbal extracts whose active ingredients have been reported to produce synergistic efect. PD-ST, PD-SP, PD-
RP, and PD-SP&RP refer to pharmacodynamic synergism of active ingredients that interact with the same target, different targets of the same 
pathway, different targets of related pathways, and different targets of the same and related pathways respectively. PK refers to 
pharmacokinetically potantiative effects. 
 
Herb or Herbal Extract 
(principal ingredients) [Ref] 










clinical trial or in 
vivo test results of 















Maubach et al. 2003] 
Synergistic anticancer effect 
of the soy isoflavonoids in 
human, which are weakly 
active in separation but 
active  in combination, peak 
isoflavone levels in urine, 
plasma and in breast milk 
are 60µM, 2µM and 0.2µM 









difficult to judge 
Randomized trial of 
24 prostate cancer 
patients in 3 groups 
each taking soy (high 
phytoestrogen), soy 




showed that high soy 
phytoestrogen diets 





Iso-Rich Soy [Jarrow 
Formulas, USA] 
Genistein is a tyrosine 
kinase inhibitor [Jing et al. 
1995] and reduced the 
transcriptional activity of 
hTERT dose-dependently 
(5~50 mM) leading to 
anticancer activity [Ouchi 
et al. 2005]. Daidzein 
(6~100µM) reduced 
expression of hTERT 
mRNA which affected 
human nonhormone-
dependent cervical cancer 
cells [Guo et al. 2004]. 
Expression of hTERT 
extends the life span of 
normal human cells 
[Kharbanda et al. 2000]. 
Effective concentration in 
combination (between 
0.2µM and 2µM) is at least 
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synergism. Genistein and 
daidzein likely interact 
with different targets of the 
same pathway. 





al.], [Yagi et al.] 
 
Antioxidant synergy 
between elements in leaf 
[Saada et al.];  Significant 
amelioration in superoxide 
dismutase and catalase 
activities in lungs, kidneys 
and liver of rats days after 
exposure to radiation  
[Saada et al.] 
 Trial of 30 adult 
females with 
bilateral occupational 
dry skin with or 
without irritant 
contact dermatitis 




appearance of fine 
wrinkling, and 
decreased erythema 
in the management 
of occupational dry 
skin and irritant 
contact 
dermatitis[West et al. 
2003]. Antioxidants 
are important for 
maintaining skin 
smoothness and for 






Oolong tea extract 
(epigallocatechin 
gallate, gallocatechin gallate, 
catechin gallate, epicatechin, 
caffeine)[Zhang et al. 
2004c] 
Synergistic antibacterial 
effect of monomeric 
polyphenols 
epigallocatechin gallate and 
catechin gallate in the 
extract as observed in S. 
mutans cells[Sasaki et al. 
2004] 
 Trial of 110 patients 
receiving tea tree oil 
regimen vs. 114 
patients receiving a 





showed that tea tree 
Various Oolong tea 
products from Fujian 
China 
Catechin gallate inhibited 
P-glytoprotein 
(30µg/ml)[Jodoin et al. 
2002] and thus the eflux of 
epigallocatechin gallate 
(50µM)[Hong et al. 2002], 
thereby potentiating the 
antibacterial effect of later. 
PK 
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Trial of 104 patients 
with impetigo 
contagiosa showed 
antibacterial effect of 
tea liquor 





theaflavins) [Zhang et al.] 
Tea extracts (-)-Epicatechin 
exhibited synergistic effects 
with (-)-epigallocatechin-3-
gallate, (-)-epicatechin-3-
gallate, and theaflavins 
against AH109A cell 














trial on the safety 
and efficacy of green 







showed values of 
total prostate-specific 
antigen constantly 






side effects or 
adverse 
effects[Bettuzzi et al. 
2006] 
Various green tea 
products 
(-)-epigallocatechin-3-
gallate inhibited  
proteasome activity[Kuhn 
et al.] , which induce 
apoptosis and show 
antitumor efficacy by 
stopping proteasome 
degradation of proteins 
crucial to apoptosis and 
cell cycle regulation. 
Epicatechin inhibited 
tyrosine kinase activity of 
PDGF-R producing 
anticancer effect 




including stimulation of 
tumor cells, angiogenesis 
and recruitment and 
regulation of tumor 
fibroblasts[Ostman 2004]. 
They may produce 
pharmacodynamic 
synergism by targeting 
different targets of related 
PD-RP 
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pathways. 
Green tea (Polyphenols: (-)-
epigallocatechin-3-ga llate, 
catechin, caffeine)[Morre et 
al. 2003a] 
Synergy in augmenting and 
prolonging sympathetic 
stimulation of thermogenesis 
in Sprague-Dawley 
rats[Dulloo et al.] 
Comparison of 
effects, effect 2.4-





Randomized trials of 
10 healthy men in 3 
groups each taking 
green tea extract, 
caffeine, and placebo 
showed that green 




that explained by its 
caffeine content per 
se[Dulloo et al. 
1999] 










break down noradrenaline 
induced cAMP. They 
collectively stimulated 
thermogenesis by relieving 
different control points 
along the NA-cAMP 




Camphor)[Viljoen et al. 
2003]  
Camphor and 1,8-cineole 
produced antibacterial 
synergism in Staphylococcus 
aureus infected cells 
[Stermitz et al. 2000] 
 No report found Revulsan [Sopharma, 
USA]  
Unknown  





et al. 2003] 
Synergistic antifungal effect 
against Aspergillus flavus, 






assays[Carpinella et al. 
2003] 
 No report found Infantile malnutrition 





Ginkgo biloba extract 
(Flavonoids: Bilobalides; 
Ginkgolides: ginkgolide A, 




neuronal death in vivo and 
glutamate-induced neuronal 
death in vitro involving anti-
excitotoxicity, inhibition of 
free radical generation, 





functioning of 262 
cognitively intact 
older adults showed 





increased mRNA levels of 
COXIII subunit of 
cytochrome c oxidase and 
subunit 1 of NADH 
dehydrogenase (ND1) thus 
preserving brain energy 
metabolism and providing 
PD-RP 
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oxygen species, and 
regulation of mitochondrial 
gene 
expression[Chandrasekaran 
et al. 2002] 
biloba extract EGb 




SRT tasks involving 
delayed free recall 




with the placebo 
controls. The EGb 
761 group also 
demonstrated 
significantly greater 
improvement on the 
WMS-III FII subtest 
assessing delayed 
recognition of visual 
material (human 
faces), compared 
with the placebo 
group[Mix et al. 
2002] 
neuroprotection[Defeudis 
2002]. Ginkgolide B 
blocked glycine-gated 
chloride channel (IC50 
0.27µM) and glycine-
activated responses in 
pyramidal hippocampal 
neurons leading to neural 
effect[Kondratskaya et al. 
2004]. Thus, 
neuroprotective synergistic 
effects may arise from 
actions at two different 





[Yesilada et al. 2002; 
Musumeci et al.] 
Antimicrobial action of 
berberine potentiated by 5'-
methoxyhydnocarpin 
[Stermitz et al. 2000] 





(1µg/ml) inhibited the 
berberine effluxing 




subinhibitory amounts of 
berberine, 5’- 
methoxyhydnocarpin 
caused complete inhibition 
of growth at a 
concentration of 1 µg/ml. 
PK 
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Berberine alone showed 
poor antimicrobial activity, 
and 5’- 
methoxyhydnocarpin alone 
had no antimicrobial 
activity at a concentration 
above 500µg/ml [Stermitz 
et al. 2000]. Hence, 5'-
methoxyhydnocarpin 








Herbal extracts produced 
anti-HIV synergy in HIV 
infected cell 














glucopyranoside 8 (EC50 
=40 µg/mL) interacted 
with viral protein gp120 
and prevented its binding 
to CD4 [Mahmood et al.], 
kaempferol inhibited viral 
protease (EC50 =2 µg/mL). 
They may produce 
pharmacodynamic 
synergism by interacting 





pinene, beta-pinene, borneol, 
caryophyllene oxide, linalool 
and bornyl acetate)[Savelev 
et al.] 
Synergistic and antagonistic 
interactions of 
anticholinesterase terpenoids 
in Salvia lavandulaefolia as 
tested in an in vitro 








trial on mood and 
cognition modulating 
effect of this herb in 
24 patients showed it 
is capable of acute 
modulation of mood 
and cognition in 






and camphor inhibited 
acetylcholinesterase at 
IC50 values of 0.67 mM, 
0.63 mM, and, 
>10mM[Perry et al.]. A 2-
compound combination 
may produce synergism if 
each interacts at different 
site or different section of 
the same site of the same 
target. A 2-compound 
combination may produce 
PD-ST 
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antagonistic effect if they 
mutally interfere at the 
same binding site. 
Helichrysum pedunculatum 
(Linoleic acid, Oleic acid, 
foleic acid)[Dilika et al.] 
Synergistic effect of linoleic 
acid and foleic acid, 
extracted from leaves of 
Helichrysum pedunculatum, 
against Staphylococcus 
aureus and Micrococcus 
kristinae with minimum 
inhibitory concentration 
0.01~1.0mg/ml as tested in 
an in vitro assay[Dilika et 
al.] 
 No report found Various body lotion 
















antagonistic action for 
relaxing the smooth muscle 
of isolated rabbit tracheas 
and pulmonary arteries[Zhao 
et al. 1999] 
 In vivo test on 
isolated tracheas and 
pulmonary arteries of 
rabbits[Zhao et al. 
1999]. Testing 









praeruptorin A at 30µM all 
have calcium antagonistic 
action, 8-methoxy-psoralen 
has inhibitory effect on 
contraction induced by 
phenylephrine, these may 
produce a synergistic effect 
for relaxing the smooth 
muscle of tracheas and 
pulmonary arteries by 
interacting with different 
targets of related 







O-glucoside, bodirin A) 
[Zhu et al. 1999] 
Synergistic effects on the 
activities of central nervous 
system determined by 
bioassay-guided isolation in 
conjunction with receptor 
binding assays[Zhu et al. 
 No report found None Bodinone, bodinone 




Ca2+ channel and 5HT-2 
PD-RP 
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1999] receptors, stigmasterol 3-
O-glucoside antagonized 
5HT-2 receptors, and 
bodirin A antagonized 
dopamine-2 receptors [Zhu 
et al. 1999]. They may 
produce pharmacodynamic 
synergism on CNS by 
interacting with different 
targets of related pathways. 
St John's wort (Hyperforin, 
hypericin, 
pseudohypericin)[Hostanska 
et al. 2003] 
Synergistic anticancer effect 
as tested on leukemia K562 










Hyperforin activated a 
caspase cascade thus 
inducing cell death in the 
dark. Hypericin activated 
caspases-8 and -3 thus 
causing light-activated 
apoptosis in various tumor 
cells[Hostanska et al. 
2003]. They collectively 
induce apoptosis by 
targeting different 








et al. 2004] 
Synergistic or additive 
antiproliferative interactions 
of the anthocyanins, 
proanthocyanidins, and 
flavonol glycosides within 
the cranberry extract against 
human tumor cell 
lines[Seeram et al. 2004] 








(Genistein, biochanin A, 
alpha-linolenic acid, gamma-
linolenic acid)[Morel et al. 
2003] 
Isoflavones extracts 
potentiate the antibacterial 
activity of alpha-linolenic 
acid by increasing the 
uptake of berberine into 
Staphylococcus aureus 
cells[Morel et al. 2003] 
 No report found United States Patent 
6,846,494 
(Nutricia,USA) 
Isoflavones (10 µg/mL) 
may inhibit a multidrug 
resistance pump, which 
increase the potency of a 
weak antibacterial alpga-
linolenic acid (MIC, 62.5 
µg/mL)[Morel et al. 2003] 
PK 
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by maintaining its 
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Table 5.4 List of pairs of herbs or herbal extracts reported to produce synergistic effects. PD-ST, PD-SP, PD-RP, and PD-SP&RP are defined in 
Table 5.3. 
 


















clinical trial or 
in vivo study of 


















Maubach et al. 2003] 
Acerola cherry 
extract (Ascorbic 









the presence of 
acerola cherry 
extract as tested 
on specific cell 
cultures[Hwang 
et al. 2001] 
Comparison of 





detection result  
reliable 
No report found Protein Powder 
and Bio C Plus 
combination 





Genistein binds to 
metmyoglobin (IC50 ~40µM) 
and inhibited Mb-dependent 
LDL oxidation, leading to 
antioxidant effect[Patel et al. 
2001]. Ascorbic acid (150µM) 
enabled metabolism of oxidant 
species H2O2 via binding to 
metmyoglobin[Galaris et al. 
1997] and thus reduced 
metmyoglobin-dependent 
LDL oxidation. They may 
produce pharmacodynamic 
synergism by interacting with 
either different sites or 
different section of the same 



















the presence of 
acerola cherry 
extract as tested 
Comparison of 





detection result  
reliable 
No report found Protein Powder 
and Bio C Plus 
combination 
[Nutrilite, USA] 
Genistein binds to 
metmyoglobin (IC50 ~40µM) 
and inhibited Mb-dependent 
LDL oxidation, leading to 
antioxidant effect [Patel et al. 
2001]. Ascorbic acid (150µM) 
enabled metabolism of oxidant 
species H2O2 via binding to 
metmyoglobin [Galaris et al. 
1997] and thus reduced 
PD-ST 
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on specific cell 
cultures[Hwang 
et al. 2001] 
metmyoglobin-dependent 
LDL oxidation. They may 
produce pharmacodynamic 
synergism by interacting with 
either different sites or 
different section of the same 












and ascorbic acid 
synergistically 
inhibited LDL 
oxidation in an in 
vitro test[Hwang 













difficult to judge. 
No report found Vitamin 
C/Flavonoid 
complex products 
Genistein binds to 
metmyoglobin (IC50 ~40µM) 
and inhibited Mb-dependent 
LDL oxidation, leading to 
antioxidant effect [Patel et al. 
2001]. Ascorbic acid (150µM) 
enabled metabolism of oxidant 
species H2O2 via binding to 
metmyoglobin [Galaris et al. 
1997] and thus reduced 
metmyoglobin-dependent 
LDL oxidation. They may 
produce pharmacodynamic 
synergism by interacting with 
either different sites or 
different section of the same 


































(EGCg) both blocked NADH 
oxidase activity of a cancer-
specific cell surface protein 
tNOX at ED50 of ~5nM 
[Morre et al. 1995] and EC50 
of 1 µM [Morre et al. 2000] 
and thus stopped the growth of 
tumour cells [Chueh et al. 
2004] by inducing tNOX 
related apoptosis [Morre et al. 
2006]. They may produce 
pharmacodynamic synergism 
PD-ST 
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by interacting with either 
different sites or different 





















serum levels of 
insulin-like 
growth factor 
(IGF)-I by soy 
and tea bioactive 
components 
leading to anti-
cancer effect as 
tested in female 
SCID 





combination and no 





Phase III trial 
being conducted 
on 154 patients 
by National 
Cancer Institute 
to test prostate 
cancer 
prevention 
activity of Soy 
isoflavones and 
green tea, 
outcome of this 























(EGCg) blocked NADH 
oxidase activity of a cancer-
specific cell surface protein 
tNOX at EC50 of 1 µM[Morre 
et al. 2000] and thus stopped 
the growth of tumor 
cells[Chueh et al. 2004] by 
inducing tNOX related 
apoptosis[Morre et al. 2006]. 
Genistein is a tyrosine kinase 
inhibito [Jing et al. 1995] and 
reduced the transcriptional 
activity of hTERT dose-
dependently (5~50 mM) 
leading to anticancer 
activity[Ouchi et al. 2005]. 
Daidzein (6~100µM) reduced 
expression of hTERT mRNA 
which affected human 
nonhormone-dependent 
cervical cancer cells[Guo et al. 
2004]. Expression of hTERT 
extends the life span of normal 
human cells[Kharbanda et al. 
2000]. They may produce 
pharmacodynamic synergism 
by interacting with different 



















No report found FastOne 
[Longevity, 
USA] 
With peptide 1-17 of gastrin as 
substrate, resveratrol (25µM) 
inhibited PC12 particulate 
tyrosine kinases without 
PD-ST 
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caffeine)[Morre et al. 
2003a] 
protection of 












likely  reliable. 
affecting soluble activity, 
catechin (100µM) inhibited 
particulate and increased 
soluble activity. When peptide 
6-20 of cell division kinase 
p34cdc2 was utilized, catechin 
(100µM) inhibited PC12 
soluble tyrosine kinase activity 
and increased particulate 
activity, resveratrol (25µM) 
inhibited both soluble and 
particulate activities[Conte et 
al.]. beta-AP induces toxicity 
by activating tyrosine kinase-
based signaling response 
which produces neurotoxic 
secretory products, 
proinflammatory cytokines, 
and reactive oxygen 
species[Combs et al. 2001]. 
These active ingredients may 
produce pharmacodynamic 
synergism by interacting with 
either different sites or 
different section of the same 





acid, ellagic acid, 
beta-carotene,  lutein, 
8-
hydroxylinalool)[Yil




Vitis vinifera and 




efficiency in in 
vitro test[Shafiee 
et al. 2002] 
 No report found NSI Grape Seed, 





Caffeine exerted antioxidant 
effect by increasing the 
activity of superoxide 
dismutase [Rossowska et al. 
1995] and by quenching 
reactive species 




cytochrome P450 CYP1A2 
[Chang et al.; Ursing et al.], 
PK 
CHAPTER 5 SYNERGISTIC EFFECTS 125 
thereby maintaining the 
concentration and thus 






















activity in the 
inhibition of lipid 
peroxidation by 
lipoxygenase as 













Trial of 10 
healthy persons 
to test the effect 







that garlic and 



















lipoxygenases (IC50 = 25 µM) 
[Prasad et al.; Teklu et al.], 
myricetin inhibited 
lipoxygenase[Robak et al.], 
kaempferol inhibited 15-
lipoxygenase and 
phospholipase A2[Alcaraz et 
al.], diallyl sulfide inhibited 
superoxide production by 
xanthine oxidase[Ou et al.]. 
They may produce 
pharmacodynamic synergism 
by interacting with different 




















activity in the 
inhibition of lipid 
peroxidation by 
lipoxygenase as 
tested in a lipid 
Comparison of 










lipoxygenases (IC50 = 25 µM) 
[Prasad et al.; Teklu et al.], 
myricetin inhibited 
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 a et al.] peroxidation 
assay[Shobana et 
al.] 
reliable phospholipase A2[Alcaraz et 
al.], [6]-gingerol effectively 
suppressed peroxynitrite-
induced oxidation of 
dichlorodihydrofluorescein[Ip
poushi et al.]. They may 
produce pharmacodynamic 
synergism by interacting with 
different targets of the same 
and related pathways. 








3 dithiin, and alliin) 
[Ariga et al.] 




iga et al.; Seki et 
al.]  

















a et al.] 
Synergistic 
antioxidant 
activity in the 
inhibition of lipid 
peroxidation by 
lipoxygenase as 












No report found Cyclone Cider 
[Kalyx.com, 
USA] 
Garlic + Ginger 
[Jarrow 
Formulas, USA] 
Diallyl sulfide inhibited 
superoxide production by 
xanthine oxidase [Ou et al.], 
[6]-gingerol effectively 
suppressed NO production of 
lipopolysaccharide (LPS)-
activated J774.1 macrophages 
iNOS (IC50 23.9 µM) 
[Ippoushi et al.]. They may 
produce pharmacodynamic 
synergism by interacting with 














of garlic and 
tomato in cancer 
preventive effect 
as tested in 
Comparison of 




In vivo test on 
cell proliferation 
inhibitory 







Diallyl disulfide inhibited 
RNA polymerase and nuclear 
RNA synthesis leading to 
possible anticancer effect[Yu 
et al.], Allicin caused a 
PD-RP 








n et al.] 
rats[Sengupta et 
al.]  
detection result may 















et al.]. Testing 
results described 
in third colomn. 
Institute, USA] transient drop in the 
intracellular glutathione level 
leading to growth inhibitory 
activity (IC50=10-
25µM)[Hirsch et al.], 
Lycopene (2-3µM) inhibited 
cell cycle progression via 
reduction of the cyclin D level 
and retention of p27 in cyclin 
E--cdk2[Nahum et al.], 
Gamma-tocopherol (25µM) 
down-regulated cyclins thus 
inhibited human cancer cell 
cycle progression and cell 
proliferation[Gysin et al.]. 
They may produce 
pharmacodynamic synergism 
by interacting with different 





of the leaves of 
Tomato (1,25-
dihydroxyvitamin 























while individual at 
same concentration 
produces no effect. 
Synergism 
detection result may 
be difficult to judge 
No report found  Lycopene (2-3µM) inhibited 
cell cycle progression via 
reduction of the cyclin D level 
and retention of p27 in cyclin 
E--cdk2[Nahum et al.], 1,25-
dihydroxyvitamin D3 (0.1 
µM) regulated mineral 




by binding to the vitamin D 
receptor[Lu et al.]. They may 
produce pharmacodynamic 
synergism by interacting with 




carotene)[Livny et al.] 
Fruits or vegetable 
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Vitamins 
E)[Czernichow et al.] 
treatment of 
nonmelanoma 
skin cancer and 
melanoma[Bialy 
et al.] 
in adults taking 
combined 
supplementation 




zinc reduced the 
rate of cancer by 
31% in men but 
not in 
women[Huang 
et al. 2006a] 
or Damaged Hair 
Vitamin E, 
















et al.; Tan et al.; Goto 






ta et al.; De Clercq; 
Kamei et al.] 
Synergy in spasm 
and pain relief 









for pain relief 
and harmonizing 
liver[Ung et al. 
2007]. It has 
been applied to 
patients without 
rigorous clinical 
test. It is thus 














Timosaponin A1, A2, 





Astragaloside I, II, 





tested in rats[Hu 
et al. 2002] 





rats. After 8 














into groups and 
medicated for 6 
weeks. Their 




























Astragaloside I, II, 





antiviral effect as 
tested in HEp-2 
cell system[Wang 
et al. 1999] 
 A trial of 60 
chronic hepatitis 
C patients orally 
taking Bing Gan 
Ling liquid 
composed 







etc. The total 
effective rate is 
86.7%, which is 
considerably 
better than that 







Emodin binds to and disrupted 
membranes by inducing 
formation of hexagonal-H(II) 
phase which lead to antiviral 
and antimicrobial effects 
(MIC50=2.2µM)[Alves et al.], 
Osthole suppressed the 
secretion of HBV by 
increasing the glycosylation of 
HBV surface antigen (20 
µg/mL)[Huang et al.]. They 
may produce 
pharmacodynamic synergism 
by interacting with different 
targets of related pathways. 
PD-RP 
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of the control 
group[You et al. 



















1989; Ozaki 1990; 
Zhang et al. 2004b]  
Gastrodia elata BI. 
{Tian-Ma}  
(vanilline, vanillic 
acid, vanillyl alcohol, 
gastrodin)[Wu et al.; 
Hsieh et al. 2000] 
Synergistic 
anticonvulsive 
effects as tested 
in male Sprague-
Dawley 







In vivo test of 
male Sprague-
Dawley rats (6 
































Hirsuteine (300 nM-10 µM) 
blocked ion permeation 
through nicotinic receptor 
channel complexes[Watano et 
al. 1993] which might 
contribute to its anticonvulsive 
effect[Krampfl et al. 2000], 
Vanillyl alcohol (200 mg/kg) 
has free radical scavenging 
activities which may be 
responsible for its 
anticonvulsive 
propertics[Hsieh et al. 2000]. 
They may produce 
pharmacodynamic synergism 
by interacting with different 
targets of related pathways. 
PD-RP 
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onset time of 





















et al. 2007]. It 
has been applied 
to patients 
without rigorous 
clinical test. It is 
thus classified 




















efficacy as found 
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Wakabayashi; 
Wozniak et al.] 
in an in vitro 














awa et al. 2004; 











u et al. 2004] 
 In vivo test of 
herb extracts fed 
to mice via 
gastric tube for 
8 weeks. The 
blood was 
collected to 
assess liver and 
renal functions. 
The tissue 
samples of the 











None   
Buckweat 









oxidation by rutin 
and gamma-
terpinene as 
shown by an in 
vitro test[Milde et 
al. 2004] 
Comparison of 











Rutin (500 µM) inhibited 
HUVEC nuclear condensation 
and fragmentation induced by 
Cu(2+)-oxidized LDL[Jeong 
et al.]. Gamma-terpinene 
efficiently slowing down the 
oxidation of LDL [Grassmann 
et al.]. They may produce 
synergism by interacting with 
different targets of 








 No report found None 4',6'-Dihydroxy-3',5'-
dimethyl-2'-methoxychalcone 
PK 



















stilbene inhibited berberine 
effluxing multidrug-resistance 
pumps with MICs of 250 and 
500 µg/mL, respectively , but 
they caused complete growth 
inhibition at very low 
concentrations (~3.3 
µg/mL)[Belofsky et al. 2004]. 
Thus the effects of berberine 
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5.4 Discussion 
5.4.1 Current opinions and investigations of herbal synergism 
 
While herbal synergism has been reported in some herbs or herbal products 
[Stermitz et al. 2000; Williamson 2001; Spinella 2002; Gilbert et al. 2003], the 
underlying molecular mechanism is mostly unknown [Williamson 2001]. In general, 
synergism between herbal ingredients has been considered to be similar to those of 
synergism from drug combinations. For instance, pharmacodynamic synergism of herbs 
results from two or more active ingredients interacting with related therapeutic or 
toxicological targets, and in some cases with additional targets involved in the related 
biological pathways. These interactions collectively produce a therapeutic or toxicity-
regulating effect that is more significant than the simple sum of effects of these 
ingredients. Pharmacokinetical potentiative effects result from one or more active 
ingredients interfering with the pharmacokinetic processes of other active ingredients. 
This interference affects the therapeutic and toxicological actions of the other ingredients 
by modulating their bioavailability. Interference with a pharmacokinetic process often 
occurs through binding to proteins responsible for absorption, distribution, metabolism, 
and excretion (ADME) of drugs and xenobiotics [Caldwell et al. 1995; Lee et al. 2004].  
 
Thus, the pharmacokinetical potentiative and toxicity modulating effects of herbal 
combination is mediated by the interaction of active ingredients with specific 
biomolecules that either directly alters pharmacodynamical activities or modulates the 
therapeutic, toxicological, and ADME effects of other active ingredients. Investigation of 
CHAPTER 5 SYNERGISTIC EFFECTS 135 
the molecular interaction profiles between active ingredients of herbs and the relevant 
biological entities can thus provide useful hint about the molecular mechanism of 
reported therapeutic efficacies and whether these are due to synergistic or placebo effects.  
 
Knowledge of molecular interaction profiles between active ingredients of herbs 
has recently been used in several studies for explaining the synergistic effects of some 
herbal ingredients [Stermitz et al. 2000; Williamson 2001; Spinella 2002]. For instance, 
some active ingredients in St. John’s wort have been found to separately inhibit catechol-
omethyltransferase, monoamine receptor and monoamine reuptake, but their 
concentrations are at levels that they are individually sub-therapeutic for depression 
[Spinella 2002]. However, these ingredients combine to produce a pharmacodynamic 
synergism that contributes to the observed anti-depression effects of this herb[Spinella 
2002]. In another example, an active ingredient in chaulmoogra oil has been found to 
potentiate the antimicrobial action of berberine in berberis plants by enhancing its 
bioavailability via inhibition of the berberine-removing multidrug pump, which is a 
typical example of pharmacokinetic potentiative effect between the two active ingredients 
[Stermitz et al. 2000]. 
 
5.4.2 Do literature-described molecular interactions of active herbal ingredients 
support the reported synergism in some herbs or herbal products? 
As shown in Table 5.3 and Table 5.4, there are 17 cases of single herb synergism 
and 22 cases of twin-herb synergism. We were able to find literature reported molecular 
interaction profiles for 12 and 16 of these cases respectively, which are summarized in 
CHAPTER 5 SYNERGISTIC EFFECTS 136 
Table 5.3 and Table 5.4. These profiles may be potentially used for supporting, 
explaining and investigating the proclaimed synergism. It appears that literature 
described MI profiles may be used for supporting 11 cases of single-herb and 16 cases of 
twin-herb synergism. Analysis of the profiles of the 11 cases of single-herb synergism 
suggests that 3 cases may be attributed to pharmacokinetically potentiative effects, and 5, 
3, 3, 1, and 1 cases may be attributable to pharmacodynamically synergistic effects 
arising from collective interaction with different targets of related pathways, different 
targets of the same pathway, different targets of both the same pathway and related 
pathways, and the same target respectively. Analysis of the molecular interaction profiles 
of the 16 cases of twin-herb synergism suggest that 2 cases may be attributed to 
pharmacokinetically potentiative effects, and 6, 5, and 3 cases may be attributable to 
pharmacodynamically synergistic effects arising from collective interaction with different 
targets of related pathways, the same target, and different targets of both the same 
pathway and related pathways, respectively. The molecular interaction profiles of these 
cases also suggest that there is no significant difference between the possible molecular 
mechanisms of synergism among the active ingredients within single-herb and between 
two herbs.  
5.4.3 Cases of pharmacodynamic synergism interacting with different targets of the 
same pathway 
In studying soy isoflavonoids’ inhibition of neoplastic transformation in human, 
soy isoflavonoids that are weakly active in separation have been found to be active in 
combination [Franke et al. 1998].  A randomized trial has been conducted to test 24 
prostate cancer patients, divided into 3 groups each taking soy (high phytoestrogen), soy 
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and linseed (high phytoestrogen), and wheat (low phytoestrogen), which has 
demonstrated that high soy phytoestrogen diets reduce risk of prostate cancer 
development and progression [Dalais et al. 2004]. The primary soy isoflavonoids are 
genistein, daidzein, dihydrodaidzein, O-desmethylangolensin, and equol [Lampe 2003; 
Maubach et al. 2003]. Genistein is a tyrosine kinase inhibitor [Jing et al. 1995] that 
reduces the transcriptional activity of human telomerase reverse transcriptase (hTERT) 
dose-dependently at 5~50mM leading to anticancer activity [Ouchi et al. 2005]. Daidzein 
at 6~100µM reduces the expression of hTERT mRNA which affected human 
nonhormone-dependent cervical cancer cells [Guo et al. 2004]. Expression of hTERT 
extends the life span of normal human cells [Kharbanda et al. 2000]. The peak isoflavone 
levels in urine, plasma and in breast milk in that study is 60µM, 2µM and 0.2µM 
respectively [Kharbanda et al. 2000]. These studies suggest that the effective 
concentration in combination (between 0.2µM and 2µM) is at least 3 fold smaller than 
that of invidual ingredient, indicative of pharmacodynamic synergism that arise from the 
interaction with different targets of the same pathway. 
 
Polyphenol extracts of green tea has been found to produce synergism in 
augmenting and prolonging sympathetic stimulation of thermogenesis in Sprague-Dawley 
rats [Dulloo et al. 2000]. A randomized trial of 10 healthy men divided into 3 groups 
each taking green tea extract, caffeine, and placebo has shown that green tea has 
thermogenic properties and promotes fat oxidation beyond that explained by its caffeine 
content per se [Dulloo et al. 1999]. The principal polyphenols of green tea are (-)-
epigallocatechin-3-gallate, catechin, and caffeine [Morre et al. 2003a]. Catechin-
CHAPTER 5 SYNERGISTIC EFFECTS 138 
polyphenols are known to inhibit catechol-O-methyl-transferase which degrades 
noradrenaline, and caffeine has been found to inhibit trancellular phosphodiesterases 
which break down noradrenaline induced cAMP. Thus these green tea ingredients 
collectively stimulate thermogenesis by relieving different control points along the NA-
cAMP axis [Dulloo et al.]. 
 
5.4.4 Cases of pharmacodynamic synergism interacting with different targets of 
related pathways 
Tea extract (-)-Epicatechin has been found to exhibit synergistic effects together 
with other extracts (-)-epigallocatechin-3-gallate, (-)-epicatechin-3-gallate, and 
theaflavins against AH109A cell proliferation [Zhang et al. 2000]. A double-blind, 
placebo-controlled trial has been conducted to test the safety and efficacy of green tea 
catechins for cancer chemoprevention in 60 high-grade prostate intraepithelial neoplasia 
volunteers, which have shown values of total prostate-specific antigen to be constantly 
lower than that of placebo-treated ones, and improved international prostate symptom 
scores, without significant side effects or adverse effects [Bettuzzi et al. 2006]. (-)-
epigallocatechin-3-gallate inhibited proteasome activity [Kuhn et al. 2004], which induce 
apoptosis and show antitumor efficacy by stopping proteasome degradation of proteins 
crucial to apoptosis and cell cycle regulation. Epicatechin inhibited tyrosine kinase 
activity of PDGF-R producing anticancer effect [Sachinidis et al. 2000] by stopping 
PDGF-R regulated multiple tumor-associated processes including stimulation of tumor 
cells, angiogenesis and recruitment and regulation of tumor fibroblasts [Ostman 2004]. 
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These studies suggest that these extracts produce pharmacodynamic synergism by 
targeting different targets of related pathways. 
 
Active ingredients of Ginkgo biloba extract have been reported to produce 
synergistic protection against ischemia-induced neuronal death in vivo and glutamate-
induced neuronal death in vitro involving anti-excitotoxicity, inhibition of free radical 
generation, scavenging of reactive oxygen species, and regulation of mitochondrial gene 
expression [Chandrasekaran et al. 2002]. A double-blind, placebo-controlled trial on 
neuropsychological functioning of 262 cognitively intact older adults has shown that 
those taking Ginkgo biloba extract EGb761 daily for 6 weeks exhibited significantly 
more improvement on SRT tasks involving delayed free recall and recognition of 
noncontextual, auditory-verbal material, compared with the placebo controls. The 
EGb761 group also demonstrated significantly greater improvement on the WMS-III FII 
subtest assessing delayed recognition of visual material (human faces), compared with 
the placebo group [Mix et al. 2002]. Bilobalide at 15~30µM increases mRNA levels of 
COXIII subunit of cytochrome c oxidase and subunit 1 of NADH dehydrogenase (ND1) 
thus preserving brain energy metabolism and providing neuroprotection [Defeudis 2002]. 
Ginkgolide B blocks glycine-gated chloride channel at IC50 0.27µM and thus glycine-
activated responses in pyramidal hippocampal neurons leading to neural effect 
[Kondratskaya et al. 2004]. Therefore, neuroprotective synergistic effects arise from 
actions at two different points of neuronal cellular processes. 
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5.4.5 Cases of pharmacodynamic synergism interacting with different targets of 
both the same and related pathways 
In an in vivo test on female SCID mices, a combination of soy and tea bioactive 
components has been found to inhibit tumor angiogenesis and reduce estrogen receptor 
(ER)-alpha and serum levels of insulin-like growth factor IGF-I leading to anti-cancer 
effect [Zhou et al. 2004]. It has been reported that the National Cancer Institute has been 
conducting Phase III trial on 154 patients to test prostate cancer prevention activity of soy 
isoflavones and green tea, even-though the outcome of this and earlier trials has not been 
made publically available [Greenwald 2004]. The main green tea polyphenols are (-)-
epigallocatechin-3-ga llate, catechin, and caffeine [Morre et al. 2003a]. Soy extract 
primarily comprises genistein, daidzein, dihydrodaidzein, O-desmethylangolensin, and 
equol [Lampe 2003; Maubach et al. 2003]. (-)-epigallocatechin-3-gallate (EGCg) blocks 
NADH oxidase activity of a cancer-specific cell surface protein tNOX at EC50 of 1 µM 
93 and thus stopped the growth of tumor cells [Chueh et al. 2004] by inducing tNOX 
related apoptosis [Morre et al. 2006]. Genistein is a tyrosine kinase inhibitor 66 and 
reduced the transcriptional activity of hTERT at 5~50 mM dose-dependently leading to 
anticancer activity [Ouchi et al. 2005]. Daidzein at 6~100µM reduced expression of 
hTERT mRNA which affected human nonhormone-dependent cervical cancer cells [Guo 
et al. 2004]. Expression of hTERT is known to extend the life span of normal human 
cells [Kharbanda et al. 2000]. These studies suggest that these active ingredients produce 
pharmacodynamic synergism by interacting with different targets of both the same 
pathway and different pathways. 
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5.4.6 Cases of pharmacodynamic synergism interacting with the same target 
 
From an in vitro test, some combinations of terpenoids in Salvia lavandulaefolia, 
an herb used as cholinergic and memory-enhancing agent, have been reported to produce 
synergistic as well as antagonistic anticholinesterase activity [Savelev et al.]. A placebo-
controlled, double-blind, balanced, crossover trial has been conducted on mood and 
cognition modulating effect of this herb in 24 patients, which shows that it is capable of 
acute modulation of mood and cognition in healthy young adults [Tildesley et al. 2005]. 
Three active ingredients, 1,8-cineole, alpha-pinene, and camphor, have been found to 
inhibit acetylcholinesterase at IC50 values of 0.67mM, 0.63mM, and >10mM 
respectively [Perry et al. 2000]. Collectively these inhibitors of weak IC50 values may 
produce sufficiently strong anticholinesterase activity to produce the observed synergism 
by mutual enhancement against the same target. Based on statistical analyis of the results 
from drug combination studies, combination of active ingredients interacting with the 
same target may produce synergism if each interacts at different site or different section 
of the same site. It may produce antagonistic effect if they mutally interfere at the same 
binding site. 1,8-cineole, alpha-pinene and camphor have been found to be uncompetitive 
reversible inhibitors [Perry et al. 2000]. Therefore, there is a much higher probability for 
them to mutually enhance than to mutually interfere with each other’s inhibitory activity, 
resulting in a pharmacodynamically synergistic effect against the same target. 
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5.4.7 Cases of pharmacokinetically potentiative effect 
 
There has been a report about the synergistic antibacterial effect of monomeric 
polyphenols epigallocatechin gallate and catechin gallate in the extract of Oolong tea as 
observed in an in vitro test on staphylococcus mutans cells [Sasaki et al. 2004]. Two 
clinical tests have been reported. In a trial of 110 patients receiving tea tree oil regimen 
vs. 114 patients receiving a standard regimen for treatment of methicillin-resistant 
staphylococcus aureus colonization, it has been showed that tea tree oil is effective, safe 
and well tolerated [Dryden et al. 2004]. Another trial of 104 patients with impetigo 
contagiosa has demonstrated antibacterial effect of tea liquor lotion [Sharquie et al. 2000]. 
Oolong tea extract contains epigallocatechin gallate, gallocatechin gallate, catechin 
gallate, epicatechin, and caffeine [Zhang et al. 2004c]. Catechin gallate is known to 
inhibit P-glycoprotein [Jodoin et al. 2002] which effluxes a major antibacterial 
component in the extract, epigallocatechin gallate [Hong et al. 2002]. Thus 
pharmacokinetic synergism of the Oolong tea extracts is likely produced by the capability 
of one of its active ingredient, catechin gallate, in effectively maintaining the level of its 




Current study raises a question whether literature-described molecular interaction 
profiles of active herbal ingredients can be explored for supporting, validating and 
investigating reported synergistic effects of herbs and herbal products. Knowledge of 
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herbal synergism from these studies may be further explored for developing novel 
cocktail therapeutic approaches to achieve synergistically enhanced therapeutic effect 
relatively free of the adverse effects produced by large doses of a single constituent. 
Molecular level study of herbal synergism is possible if the currently available literature-
described molecular interaction profiles of active herbal ingredients are comprehensive 
enough to cover a diverse spectrum of herbs. Search of the Medline literature 
database[Wheeler et al. 2004] found that current available literatures contain information 
about experimentally indicated molecular interaction profiles for more than 1,876 active 
ingredients from more than 1,239 herbs. Overall these active ingredients are known to 
interact with at least 970 distinct proteins, many of which are therapeutic targets, 
toxicologically-related proteins and ADME-associated proteins. Therefore, current 
information seems to have reached a meaningful level for the preliminary study of 
molecular mechanism of some herbs.   
 
A total of 39 such cases were collected from a search of Medline[Wheeler et al. 
2004] literatures followed by the search of the active ingredients of the herbs involved. 
These cases can be further divided into 17 cases of single-herb synergism given in Table 
5.3, and 22 cases of twin-herb synergism given in Table 5.4. The molecular interaction 
profiles of the active ingredients of these herbs were then retrieved from a search of 
Medline literatures. These profiles were subsequently studied to evaluate whether they 
support the reported synergism.  
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There is a need to evaluate the analysis methods used for identifying herbal 
synergism. As shown in Table 5.3 and Table 5.4, herbal synergism has primarily been 
identified based upon the observation of either enhanced effects or reduced effective 
concentrations. While these approaches can be straightforwardly applied for identifying 
herbal synergism arising from pharmacokinetically potentiative effects, careful analysis is 
needed in applying them for identifying pharmacodynamic synergism, particularly for 
distinguishing synergistic and additive effects [Peters et al. 2000; Barrera et al. 2005; 
Jonker et al. 2005; Chou 2006; Tallarida 2007].  
 
 
The majority of the reported cases of herbal synergism analyzed in this study 
appeared to be potentially supportable and explainable by the literature-described 
molecular interaction profiles of the relevant herbal ingredients. Most of these reported 
cases of synergism are of the pharmacodynamic type, in which multiple components of a 
disease or symptom-related process are inhibited or modulated by the ingredients in 
different constituent herbs of a multi-herb product. These are consistent with numerous 
experimental findings that simultaneous targeting of multiple components of a disease 
process can be more effective in the treatment of that disease. For instance, it is known 
that several mutations are required for the development of colorectal and other cancers 
[Kinzler et al. 1996] and the correction of these defective pathways require several 
interventions [Keith et al. 2005] which is the main reason for why oncological 
chemotherapeutic regiments most often involve the use of combination therapies such as 
CHOP (doxorubicin, cyclophosphamide vincristine, and prednisone) [Devita 1997]. 
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Some of the reported cases of herbal synergism are of pharmacokinetic type, in 
which the efflux pump or metabolizing enzyme of one or more therapeutically active 
ingredient of an herb is inhibited or modulated by an ingredient of another herb. 
Inhibition of drug efflux pumps has been explored as one of the key strategies for 
reversing multi-drug resistance or maintaining the levels of drug concentration thereby 
enhancing the efficacy of drugs [Robert et al. 2003]. There are also clinical trials for 
combination drugs that contain a drug and the inhibitor of its metabolizing enzyme. For 
instance, a combination of NMDA antagonist dextromethorphan and the inhibitor of its 
metabolizing enzyme, cytochrome P450 CYP2D6, quinidine is currently undergoing 
Phase III trial [Adis International Limited 2005]. Therefore, it is not surprising that such 
kind of pharmacokinetic synergy has been empirically explored in herb-based products 
and medicines[Spinella 2002], and some of the natural product efflux pump and 
metabolizing enzyme inhibitors are being investigated for therapeutic applications 
[Zhang et al. 2004a]. 
 
The present study is focused on the molecular interaction profiles of the active 
ingredients most relevant to the literature-reported synergistic effect of the herbs and 
herbal products studied. Apart from the reported synergistic effects, other effects of these 
herbs and herbal products are not considered. The active ingredients of these herbs and 
herbal products are known to interact with other molecular entities than those described. 
A more complete picture of the overall effects of these herbs and herbal products needs to 
be given based on the analysis of all of these molecular interaction profiles.   
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Besides, molecular interaction profiles may also be potentially explored for 
facilitating the identification of herbal synergism not yet discovered by the current 
investigations. For instance, studies on Isatis tinctoria by Hamburger et al. have 
identified a number of anti-inflammatory ingredients that include tryptanthrin (dual 
inhibitor of COX-2 and 5-lipoxygenase), apha-linolic acid (COX-2 inhibitor), and 
indirubin (inhibitor of chemokine RANTES) [Mohn et al. 2007]. Newly developed dual 
COX-5-lipoxygenase (5-LOX) inhibitors share the anti-inflammatory effect and gastric 
safety of COX-2 inhibitors, but also inhibit COX-1-mediated platelet function and 5-
LOX-mediated synthesis of gastrotoxic leukotrienes [de Gaetano et al. 2003]. Chemokine 
RANTES (regulated on activation normal T cell expressed and secreted) is expressed in 
several inflammatory diseases of the central nervous system and is a powerful stimulus 
for astrocyte production of proinflammatory mediators [Zhang et al. 2003]. Therefore, 
these active ingredients may produce synergistic effects by at least two main actions: one 
is efficacy synergism plus toxicity antagonism via dual inhibition of COX-2 and 5-
lipoxygenase, and the other is inhibition of two targets in related pathways. 
 
Investigation into the existence of herbal synergism can be enhanced with further 
accumulation of the information about active ingredients of herbs and their molecular 
interaction profiles, expansion of the knowledge of molecular networks in human and 
disease processes, and in the understanding of mechanism of actions of synergistic 
interactions. It is feasible to adopt bioinformatics approaches that integrate all of these 
relevant information to facilitate the identification and understanding of synergism in 
herbs and multi-herb recipes.  
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Chapter 6 Conclusion 
 
 
This last chapter summarizes the major contributions and findings for the work 
described in Chapter 2 to Chapter 5. In addition, limitations of the present work and 
suggestions for future studies are also discussed. 
 
6.1 Major Contributions and Findings 
 
 
 In this section major contributions and findings of using in silico approaches are 
discussed. As far as we know current study is the first attempt to use novel TCM 
digitalization algorithms in machine learning methods to address the scientific basis of 
formulating TCM prescriptions and herb pairs. In addition, the current study is also the 
first to use an inverse docking approach to explore the anti-metastasis mechanisms of 
Rhubarb anthraquinones such as emodin and aloe-emodin especially in the mechinism of 
inducing a metastatic suppressor gene nm23 via nuclear receptors. Besides, a 
comprehensive survey of the mechanisms of herbal synergism by literature-based 
approach was also conducted. 
 
6.1.1 Merits of MLMs in the studies of TCM from traditional view point 
 
 
             Developing a novel TCM digitalization algorithm from TCM-HP is one of the 
merits in this study. A TCM-HP digitization algorithm has been developed and used for 
computing digital TCM-HPs, which have been applied for classifying TCM prescriptions 
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[Su 1997; Wang et al. 2005a]. However, by using this algorithm, the number of digital 
TCM-HPs for each recipe is dependent on the number of its constituent herbs, which 
gives feature vectors of unequal components thereby introducing statistical noise to many 
MLM classification systems. In this study, a new algorithm was introduced to derive 
digital TCM-HPs of fixed length independent of the number of constituent herbs in a 
recipe. The second merit in using TCM digitalization algorithm in study of TCM 
prescriptions is that a significantly higher number of TCM prescriptions and non-TCM 
recipes than those in other studies [Wang et al. 2005a] were used for training and testing 
the MLM systems. Moreover, two different MLM methods were used, which were 
evaluated by two separate testing methods, to adequately examine the usefulness of 
TCM-HPs in distinguishing between TCM prescriptions and non-recipes. Overall these 
MLM systems correctly classified 83.1%~97.3% of the TCM prescriptions, 
90.8%~92.3% of the non-TCM recipes. Hence current study suggests that TCM-HPs are 
capable of separating TCM prescriptions from non-TCM recipes, which are useful for 
formulating TCM prescriptions and consistent with the expected correlation between 
TCM-HPs and the physicochemical properties of herbal ingredients responsible for 
producing the collective pharmacological and other effects of specific TCM prescriptions. 
 
We further ultilize novel TCM digitalization algorithm in MLMs to analyze distribution 
patterns of TCM-HPs to detect signs of possible synergism in TCM herb pairs. Patterns 
of 394 known TCM herb-pairs were found to exhibit signs of herb-pair correlation. 
Overall these MLM systems correctly classified 72.1%~87.9% of 394 TCM herb-pairs 
and 91.6%~97.6% of 2,470 non-TCM herb-pairs. The best MLM system predicted 96.3% 
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of the 27 known non-TCM herb-pairs and 99.7% of the other 1,065,100 possible herb-
pairs as non-TCM herb-pairs. Hence, our studies suggest that TCM-HPs of known TCM 
herb-pairs contain features distinguishable from those of non-TCM herb-pairs consistent 
with their claimed synergistic or modulating combinations. 
 
6.1.2 Merits of using inverse docking approach in the study of anti-metastatic 
activities of Rhubarb Anthraquinones 
 
Previous experimental and proteomic works indicated that Rhubarb 
anthraquinones exhibit anti-proliferative and anti-metastatic activity. However, the 
molecular targets and mechanism of anti-metastatic activity of these anthraquinones are 
poorly understood. The merit in this study is that an in silico inverse docking approach 
(INVDOCK) is utilized to perform “in silico screening” for putative metastatic-related 
molecular targets of Rhubarb anthraquinones emodin, aloe-emodin, and rhein from a 
protein structure database. Targets that are known to involve in metastasis processes such 
as matrix metalloproteinases, EGRF, tyrosine kinases are the INVDOCK-identified 
targets for these Rhubarb anthraquinones. Some of these targets had been verified 
experimentally as discussed in Chapter 4. Current study also identified nuclear receptors 
such as estrogen receptor, androgen receptor, and thyroid hormone receptor as targets of 
these anthraquinones. Since nuclear receptors regulate the expression of one of metastatic 
suppressor gene, nm23, as discussed in Chapter 4 current study provides some insight of 
regulation of nm23 activities by Rhubarb anthraquinones. Thus the in silico results 
suggest the direction on future experimental tests on activity relationship of Rhubarb 
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anthraquinones with nuclear receptors and their ability to suppress the activity of 
metastasis cells.  
6.1.3 Merits of using literature-based approach in the study of mechanism of herbal 
synergism 
 
There have been different views about the therapeutic efficacy of herbal 
supplements and medicinal herbs. Their use in therapeutics is primarily based on the 
hypothesis that multiple ingredients are better than one. The reported efficacy of certain 
herbs at apparently lower doses of active constituents suggests a need for molecular study 
to determine whether the efficacy is due to placebo or synergistic effects. Knowledge of 
synergism in some herbs, if confirmed, may be further explored for developing novel 
cocktail therapeutics. Current study provides the first in-depth and comprehensive 
analysis of studies from rigorous molecular study of clinical drug combinations (non-
herbal) to exhibit molecular interaction profiles that likely to contribute to herbal 
synergism. Overall, this study compiles the multiple mechanisms reported to be involved 
in herbal synergisms. 
 
6.2 Limitations and Suggestions for Future Studies 
 
 
 The performance of machine learning methods critically depends on the diversity 
of data in training set. The dataset used in this works are not expected to fully represent 
all TCM prescriptions and herb pairs. More diverse pharmacological groups of TCM 
prescriptions and herb pairs are required to further improve the robustness and 
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performance of current MLM systems. Besides, other traditional aspects of TCM such as 
the correlation of TCM-HPs with disease syndromes and the molecular basis of TCM-
HPs are not yet explored. All these works require us to redesign our current algorithm of 
TCM digitalization based on TCM-HPs and descriptions used to describe molecular 
properties.  
 
 For the structural strategy using INVDOCK the result validations depend heavily 
on how well a compound is studied from available experimental reports. The lack of 
sufficient experimental data is the major factor for INVDOCK validation. Since 
INVDOCK select a putative binding targets of a compound based on chemical 
complementality and energy score “false hits” may be generated if irrelevant structures 
that show certain degree of structural fitness. Currently we have no general rule to 
eliminate these false hits simply based on energy function. Inclusion of other criteria such 
as proteomics and gene expression profiles should enhance the performance of 
INVDOCK by eliminating some targets that are not actually present in a cell type.  
 
 In the literature-based approach using a set of appropriate combinations of 
keywords is improtant to mine relevant data. Expert manual reading on these literatures is 
required in order to accurately identify the relavent information. Similar to validation of 
INVDOCK results, literature-based approach is heavily limited by current available 
experimental works reported. However, current development of high throughput 
screening tools and analysis methods used in “omics” works such as clustering methods 
used in microarray analysis had helped the correlation analysis of huge data possible.  
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 It is still a long way for us to fully understand the holistic pharmacological 
mechanisms of TCM. Current study uses some well established supervised in silico 
methods in the study of TCM. Other unsupervised in silico methods such as clustering 
methods that had been widely used in microarray gene analysis can be applied to explore 
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